| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH1 MYH4 MYH11 MYO1D KIF24 DNAH14 KIF5A DNAH5 DNAH8 DYNC1H1 KIF11 DNAH3 DNAH10 KIF26B DNAH2 MYO18A DNAH7 DNAH1 SMC3 | 8.56e-15 | 118 | 292 | 19 | GO:0003774 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.17e-12 | 18 | 292 | 9 | GO:0008569 | |
| GeneOntologyMolecularFunction | microtubule motor activity | KIF24 DNAH14 KIF5A DNAH5 DNAH8 DYNC1H1 KIF11 DNAH3 DNAH10 KIF26B DNAH2 DNAH7 DNAH1 SMC3 | 1.39e-12 | 70 | 292 | 14 | GO:0003777 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH4 MYH11 MYO1D ABCA13 SRP54 KIF24 DNAH14 DDX6 HELB DDX50 HFM1 KIF5A DNAH5 DNAH8 DYNC1H1 KIF11 ATP8B3 DNAH3 DNAH10 KIF26B DNAH2 MYO18A TWNK DDX56 CHD7 RFC5 DNAH7 DNAH1 RAD50 ABCA6 SMC3 GET3 CCT8 | 2.87e-11 | 614 | 292 | 34 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.46e-10 | 28 | 292 | 9 | GO:0051959 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 6.46e-10 | 5 | 292 | 5 | GO:0047020 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH4 ABCA13 SRP54 DDX6 HELB DDX50 HFM1 KIF5A DNAH5 DNAH8 DYNC1H1 ATP8B3 DNAH3 DNAH10 DNAH2 MYO18A TWNK DDX56 CHD7 RFC5 DNAH7 RAD50 ABCA6 SMC3 GET3 CCT8 | 1.91e-09 | 441 | 292 | 26 | GO:0016887 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.35e-09 | 37 | 292 | 9 | GO:0045505 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 4.48e-08 | 4 | 292 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 4.48e-08 | 4 | 292 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 4.48e-08 | 4 | 292 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 2.03e-07 | 30 | 292 | 7 | GO:0018455 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 2.21e-07 | 5 | 292 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 2.21e-07 | 5 | 292 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 2.21e-07 | 5 | 292 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 2.21e-07 | 5 | 292 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 2.21e-07 | 5 | 292 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 2.21e-07 | 5 | 292 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH4 ABCA13 SRP54 DDX6 HELB RAB4B DDX50 HFM1 KIF5A ATL2 DNAH5 DNAH8 RAB4A DYNC1H1 ATP8B3 DNAH3 DNAH10 DNAH2 MYO18A TWNK DDX56 CHD7 ARHGAP35 RFC5 DNAH7 RAD50 ABCA6 SMC3 GET3 CCT8 RAB37 | 4.20e-07 | 775 | 292 | 31 | GO:0017111 |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 6.57e-07 | 6 | 292 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH4 ABCA13 GARS1 SRP54 DDX6 HELB RAB4B DDX50 HFM1 KIF5A ATL2 DNAH5 DNAH8 RAB4A DYNC1H1 ATP8B3 DNAH3 DNAH10 DNAH2 MYO18A TWNK DDX56 CHD7 ARHGAP35 RFC5 DNAH7 RAD50 ABCA6 SMC3 GET3 CCT8 RAB37 | 7.67e-07 | 839 | 292 | 32 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH4 ABCA13 GARS1 SRP54 DDX6 HELB RAB4B DDX50 HFM1 KIF5A ATL2 DNAH5 DNAH8 RAB4A DYNC1H1 ATP8B3 DNAH3 DNAH10 DNAH2 MYO18A TWNK DDX56 CHD7 ARHGAP35 RFC5 DNAH7 RAD50 ABCA6 SMC3 GET3 CCT8 RAB37 | 7.87e-07 | 840 | 292 | 32 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH4 ABCA13 GARS1 SRP54 DDX6 HELB RAB4B DDX50 HFM1 KIF5A ATL2 DNAH5 DNAH8 RAB4A DYNC1H1 ATP8B3 DNAH3 DNAH10 DNAH2 MYO18A TWNK DDX56 CHD7 ARHGAP35 RFC5 DNAH7 RAD50 ABCA6 SMC3 GET3 CCT8 RAB37 | 7.87e-07 | 840 | 292 | 32 | GO:0016818 |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 1.51e-06 | 7 | 292 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.67e-06 | 26 | 292 | 6 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.12e-06 | 27 | 292 | 6 | GO:0008106 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2.99e-06 | 8 | 292 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 2.99e-06 | 8 | 292 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 2.99e-06 | 8 | 292 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 5.33e-06 | 9 | 292 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 5.33e-06 | 9 | 292 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 6.11e-06 | 32 | 292 | 6 | GO:0004033 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH4 MYH11 MYO1D OBSCN CEACAM8 RYR1 RYR2 PHKA1 PHKA2 PHKB PHKG1 KCNN4 SNTA1 | 7.92e-06 | 230 | 292 | 14 | GO:0005516 |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 8.37e-06 | 20 | 292 | 5 | GO:0004303 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 8.78e-06 | 10 | 292 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 8.78e-06 | 10 | 292 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | phosphorylase kinase activity | 1.22e-05 | 4 | 292 | 3 | GO:0004689 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 2.19e-05 | 24 | 292 | 5 | GO:0004745 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH4 MYH11 NCALD MYO1D GAS2 OBSCN CEACAM8 CKAP5 PEX14 ADGRV1 NEDD1 KIF24 CEP350 HPCA MRTFB DST NFKB1 PXN KIF5A TAGLN PLS3 KIF11 AMPD1 ANK2 KIF26B MYO18A LMTK2 FSD1 SMC3 APPL1 SNTG2 CEP295 SNTA1 | 3.11e-05 | 1099 | 292 | 34 | GO:0008092 |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 3.99e-05 | 14 | 292 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 3.99e-05 | 14 | 292 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.10e-04 | 33 | 292 | 5 | GO:0033764 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN9 NCALD SYT9 ADGRV1 ZZEF1 MELK RYR1 RYR2 ITPR2 ITPR3 HPCA NELL1 DST NRXN1 HPCAL1 PLS3 PCDH11Y SYT6 SCGN DNAH7 GUCA1C CGREF1 PLCH2 ANKEF1 MICU2 | 1.15e-04 | 749 | 292 | 25 | GO:0005509 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.17e-04 | 18 | 292 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | lipid binding | CYP3A5 CYP11A1 DAB1 OBSCN CEACAM8 DAB2 SYT9 AKR1C4 WASHC2A MELK AKR1C1 AKR1C2 FABP6 ITPR2 ITPR3 COMMD1 FER MCF2L WASHC2C SH3GL2 SYT6 TWNK ARHGAP35 TLR10 CPTP PPT1 TLR4 AKR1C3 GSDMA APPL1 | 1.30e-04 | 988 | 292 | 30 | GO:0008289 |
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 2.13e-04 | 2 | 292 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 2.48e-04 | 39 | 292 | 5 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.80e-04 | 40 | 292 | 5 | GO:0016709 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 4.68e-04 | 11 | 292 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 4.91e-04 | 95 | 292 | 7 | GO:0005546 | |
| GeneOntologyMolecularFunction | NADPH binding | 5.20e-04 | 26 | 292 | 4 | GO:0070402 | |
| GeneOntologyMolecularFunction | helicase activity | 5.43e-04 | 158 | 292 | 9 | GO:0004386 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 6.33e-04 | 3 | 292 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 6.33e-04 | 3 | 292 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.03e-03 | 31 | 292 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 1.17e-03 | 32 | 292 | 4 | GO:0140142 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.25e-03 | 4 | 292 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.25e-03 | 4 | 292 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.31e-03 | 33 | 292 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.47e-03 | 34 | 292 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.52e-03 | 115 | 292 | 7 | GO:0004497 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 1.64e-03 | 35 | 292 | 4 | GO:0043325 | |
| GeneOntologyMolecularFunction | tubulin binding | NCALD GAS2 CKAP5 PEX14 NEDD1 KIF24 CEP350 DST KIF5A KIF11 KIF26B FSD1 SMC3 APPL1 CEP295 | 1.68e-03 | 428 | 292 | 15 | GO:0015631 |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 1.83e-03 | 36 | 292 | 4 | GO:0070273 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 1.83e-03 | 60 | 292 | 5 | GO:0016655 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 2.03e-03 | 121 | 292 | 7 | GO:1902936 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 2.07e-03 | 5 | 292 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 2.12e-03 | 62 | 292 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 2.12e-03 | 62 | 292 | 5 | GO:0016627 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.24e-03 | 38 | 292 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP2D6 CYP3A5 CYP11A1 AKR1C4 AKR1C1 PTGS1 AKR1C2 P4HA1 AKR1C3 | 2.28e-03 | 194 | 292 | 9 | GO:0016705 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | OBSCN CEACAM8 DAB2 SYT9 WASHC2A ITPR2 ITPR3 COMMD1 MCF2L WASHC2C GSDMA APPL1 | 2.50e-03 | 316 | 292 | 12 | GO:0035091 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.67e-03 | 127 | 292 | 7 | GO:0016616 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.67e-03 | 127 | 292 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | phospholipid binding | DAB1 OBSCN CEACAM8 DAB2 SYT9 WASHC2A ITPR2 ITPR3 COMMD1 MCF2L WASHC2C SYT6 ARHGAP35 CPTP PPT1 GSDMA APPL1 | 3.06e-03 | 548 | 292 | 17 | GO:0005543 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 3.08e-03 | 6 | 292 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.39e-03 | 21 | 292 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 4.24e-03 | 138 | 292 | 7 | GO:0016614 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-5-phosphate binding | 4.41e-03 | 23 | 292 | 3 | GO:0010314 | |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH4 MYH11 NCALD MYO1D GAS2 CEACAM8 HPCA MRTFB DST TAGLN PLS3 MYO18A SNTG2 SNTA1 | 4.83e-03 | 479 | 292 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | molecular carrier activity | 5.12e-03 | 108 | 292 | 6 | GO:0140104 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 5.26e-03 | 48 | 292 | 4 | GO:0016620 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 5.22e-10 | 5 | 289 | 5 | GO:0120256 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 3.78e-08 | 4 | 289 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 3.78e-08 | 4 | 289 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 3.78e-08 | 4 | 289 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 3.78e-08 | 4 | 289 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.24e-07 | 10 | 289 | 5 | GO:0046137 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 1.87e-07 | 5 | 289 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 1.87e-07 | 5 | 289 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 1.87e-07 | 5 | 289 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 1.87e-07 | 5 | 289 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 1.87e-07 | 5 | 289 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 5.54e-07 | 6 | 289 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 5.54e-07 | 6 | 289 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 1.28e-06 | 7 | 289 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 1.28e-06 | 7 | 289 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 1.28e-06 | 7 | 289 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 2.01e-06 | 16 | 289 | 5 | GO:0032351 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 2.84e-06 | 45 | 289 | 7 | GO:0008207 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 3.85e-06 | 18 | 289 | 5 | GO:0030656 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 3.99e-06 | 88 | 289 | 9 | GO:0071277 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 4.50e-06 | 9 | 289 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 7.42e-06 | 10 | 289 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 7.42e-06 | 10 | 289 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 7.42e-06 | 10 | 289 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 7.42e-06 | 10 | 289 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 8.83e-06 | 21 | 289 | 5 | GO:0016114 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | EPHX2 RDH8 CYP2D6 CYP3A5 CYP11A1 DAB2 AKR1C4 AKR1C1 PTGS1 AKR1C2 CBR1 AKR1C3 | 9.36e-06 | 180 | 289 | 12 | GO:0120254 |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 1.13e-05 | 22 | 289 | 5 | GO:1902644 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.15e-05 | 11 | 289 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.15e-05 | 11 | 289 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | response to calcium ion | AKR1C4 ADGRV1 AKR1C1 AKR1C2 RYR1 RYR2 ITPR3 HPCA NRXN1 ECT2 AKR1C3 | 1.75e-05 | 161 | 289 | 11 | GO:0051592 |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.84e-05 | 106 | 289 | 9 | GO:0034308 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | PEX14 CEP128 KIF24 PGK2 DNAH14 FSIP2 DST KIF5A DNAH5 DNAH8 DYNC1H1 KIF11 DNAH3 DNAH10 KIF26B DNAH2 SPG11 DNAH7 NSUN7 DNAH1 | 2.32e-05 | 493 | 289 | 20 | GO:0007018 |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 2.70e-05 | 26 | 289 | 5 | GO:0010566 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 3.38e-05 | 14 | 289 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 3.38e-05 | 14 | 289 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 3.94e-05 | 28 | 289 | 5 | GO:0048025 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.18e-05 | 67 | 289 | 7 | GO:0019748 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | CEP128 PGK2 DNAH14 FSIP2 DNAH5 DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 NSUN7 DNAH1 | 4.33e-05 | 210 | 289 | 12 | GO:0060294 |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 4.56e-05 | 15 | 289 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 4.70e-05 | 29 | 289 | 5 | GO:0050686 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | CEP128 PGK2 DNAH14 FSIP2 DNAH5 DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 NSUN7 DNAH1 | 5.44e-05 | 215 | 289 | 12 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | CEP128 PGK2 DNAH14 FSIP2 DNAH5 DNAH8 DNAH3 DNAH10 DNAH2 DNAH7 NSUN7 DNAH1 | 5.44e-05 | 215 | 289 | 12 | GO:0001539 |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 6.02e-05 | 16 | 289 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | cilium movement | CEP128 PGK2 DNAH14 FSIP2 DNAH5 DNAH8 DYNC1H1 DNAH3 DNAH10 DNAH2 DNAH7 NSUN7 DNAH1 | 8.60e-05 | 261 | 289 | 13 | GO:0003341 |
| GeneOntologyBiologicalProcess | steroid metabolic process | EPHX2 RDH8 CYP2D6 CYP3A5 CYP11A1 DAB2 UGT2A2 AKR1C4 HMGCS2 AKR1C1 AKR1C2 FABP6 NFKB1 FGFR1 CBR1 AKR1C3 | 8.82e-05 | 376 | 289 | 16 | GO:0008202 |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 8.98e-05 | 33 | 289 | 5 | GO:0033119 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.16e-04 | 105 | 289 | 8 | GO:0006721 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 1.20e-04 | 35 | 289 | 5 | GO:0120255 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 1.30e-04 | 56 | 289 | 6 | GO:0006693 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 1.38e-04 | 36 | 289 | 5 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 1.38e-04 | 36 | 289 | 5 | GO:0008299 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 1.43e-04 | 57 | 289 | 6 | GO:0006692 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 1.58e-04 | 58 | 289 | 6 | GO:0032350 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 1.79e-04 | 38 | 289 | 5 | GO:0048384 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.87e-04 | 21 | 289 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 1.87e-04 | 21 | 289 | 4 | GO:0048385 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 1.87e-04 | 21 | 289 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 1.87e-04 | 21 | 289 | 4 | GO:0042574 | |
| GeneOntologyBiologicalProcess | protein localization to M-band | 1.96e-04 | 2 | 289 | 2 | GO:0036309 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CKAP5 PEX14 NEDD1 CEP128 KIF24 PGK2 DNAH14 CEP350 FSIP2 DST FER KIF5A DNAH5 DNAH8 DYNC1H1 KIF11 DNAH3 DNAH10 KIF26B CNTRL DNAH2 SPG11 FSD1 STIL DNAH7 NSUN7 DNAH1 C2CD3 SMC3 CEP295 | 2.03e-04 | 1058 | 289 | 30 | GO:0007017 |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 2.26e-04 | 22 | 289 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 2.26e-04 | 22 | 289 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | parturition | 2.26e-04 | 22 | 289 | 4 | GO:0007567 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 2.30e-04 | 40 | 289 | 5 | GO:0042573 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 2.55e-04 | 89 | 289 | 7 | GO:0001523 | |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 2.59e-04 | 41 | 289 | 5 | GO:0070286 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 2.71e-04 | 23 | 289 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.71e-04 | 23 | 289 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 2.90e-04 | 42 | 289 | 5 | GO:0071398 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 3.57e-04 | 94 | 289 | 7 | GO:0016101 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 4.11e-04 | 69 | 289 | 6 | GO:0070542 | |
| GeneOntologyBiologicalProcess | cyclooxygenase pathway | 4.13e-04 | 11 | 289 | 3 | GO:0019371 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 4.52e-04 | 128 | 289 | 8 | GO:0033559 | |
| GeneOntologyBiologicalProcess | regulation of macropinocytosis | 5.82e-04 | 3 | 289 | 2 | GO:1905301 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 5.82e-04 | 3 | 289 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 5.83e-04 | 133 | 289 | 8 | GO:0006766 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 6.80e-04 | 29 | 289 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 8.70e-04 | 109 | 289 | 7 | GO:0035082 | |
| GeneOntologyBiologicalProcess | regulation of pinocytosis | 8.84e-04 | 14 | 289 | 3 | GO:0048548 | |
| GeneOntologyBiologicalProcess | response to redox state | 8.84e-04 | 14 | 289 | 3 | GO:0051775 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 8.96e-04 | 142 | 289 | 8 | GO:0006690 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 9.81e-04 | 144 | 289 | 8 | GO:0006720 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 9.96e-04 | 32 | 289 | 4 | GO:2000353 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.49e-08 | 25 | 289 | 7 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 5.03e-08 | 54 | 289 | 9 | GO:0030286 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.16e-07 | 10 | 289 | 5 | GO:0036156 | |
| GeneOntologyCellularComponent | phosphorylase kinase complex | 1.77e-07 | 5 | 289 | 4 | GO:0005964 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH1 MYH4 MYH11 GAS2 OBSCN CKAP5 KIF24 DNAH14 RYR1 RYR2 DDX6 DST TRIM55 KIF5A DNAH5 DNAH8 PLS3 DYNC1H1 KIF11 COL5A1 DNAH3 COL11A1 ANK2 DNAH10 KIF26B KRT34 KRT82 DNAH2 MYO18A FSD1 DNAH7 DNAH1 RADIL IFFO2 CCT8 CEP295 ARHGAP18 KRT36 | 1.06e-06 | 1179 | 289 | 38 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH1 MYH4 MYH11 GAS2 OBSCN CKAP5 KIF24 DNAH14 RYR1 RYR2 DDX6 DST TRIM55 KIF5A DNAH5 DNAH8 PLS3 DYNC1H1 KIF11 COL5A1 DNAH3 COL11A1 ANK2 DNAH10 KIF26B KRT34 KRT82 DNAH2 MYO18A FSD1 DNAH7 DNAH1 RADIL IFFO2 CCT8 CEP295 ARHGAP18 KRT36 | 1.25e-06 | 1187 | 289 | 38 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule associated complex | DNAH14 PXN KIF5A DNAH5 DNAH8 DYNC1H1 KIF11 DNAH3 DNAH10 DNAH2 DNAH7 DNAH1 | 2.59e-06 | 161 | 289 | 12 | GO:0005875 |
| GeneOntologyCellularComponent | microtubule | CKAP5 KIF24 DNAH14 DST TRIM55 KIF5A DNAH5 DNAH8 DYNC1H1 KIF11 DNAH3 DNAH10 KIF26B DNAH2 FSD1 DNAH7 DNAH1 RADIL CCT8 CEP295 ARHGAP18 | 1.84e-05 | 533 | 289 | 21 | GO:0005874 |
| GeneOntologyCellularComponent | myosin filament | 2.07e-05 | 25 | 289 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | PGK2 DNAH14 DDX6 FSIP2 DNAH5 DNAH8 DNAH3 DNAH10 PCDH11Y DNAH2 WBP2NL DNAH7 DNAH1 | 2.92e-05 | 238 | 289 | 13 | GO:0097729 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | GAS2 CKAP5 KIF24 DNAH14 DDX6 DST TRIM55 KIF5A DNAH5 DNAH8 PLS3 DYNC1H1 KIF11 DNAH3 DNAH10 KIF26B KRT34 KRT82 DNAH2 FSD1 DNAH7 DNAH1 RADIL IFFO2 CCT8 CEP295 ARHGAP18 KRT36 | 5.59e-05 | 899 | 289 | 28 | GO:0099513 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | CKAP5 HPCA DST KIF5A DNAH5 DNAH8 DYNC1H1 DNAH3 RANGAP1 DNAH10 CNTRL DNAH2 DNAH7 DNAH1 | 1.44e-04 | 317 | 289 | 14 | GO:0032838 |
| GeneOntologyCellularComponent | nuclear envelope | SCRN1 CEP128 PTGS1 GTF3C3 RYR2 ITPR3 NELL1 DST NRXN1 INTS2 TMEM147 DYNC1H1 KPNA4 IPO5 RANGAP1 RANBP3 EI24 CPTP XPO7 | 3.18e-04 | 560 | 289 | 19 | GO:0005635 |
| GeneOntologyCellularComponent | cilium | GRXCR1 ADGRV1 NEDD1 CEP128 PTGS1 PGK2 DNAH14 DDX6 FSIP2 KIF5A DNAH5 DNAH8 DNAH3 DNAH10 CNTRL PCDH11Y DNAH2 WBP2NL ARHGAP35 DNAH7 DNAH1 C2CD3 GUCA1C TBC1D31 CEP83 CCT8 | 3.26e-04 | 898 | 289 | 26 | GO:0005929 |
| GeneOntologyCellularComponent | insulin-responsive compartment | 3.97e-04 | 11 | 289 | 3 | GO:0032593 | |
| GeneOntologyCellularComponent | cytoplasmic region | CKAP5 HPCA DST KIF5A DNAH5 DNAH8 DYNC1H1 DNAH3 RANGAP1 DNAH10 CNTRL DNAH2 DNAH7 DNAH1 | 5.23e-04 | 360 | 289 | 14 | GO:0099568 |
| GeneOntologyCellularComponent | myosin II complex | 5.64e-04 | 28 | 289 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | A band | 7.45e-04 | 52 | 289 | 5 | GO:0031672 | |
| GeneOntologyCellularComponent | syntrophin complex | 1.12e-03 | 4 | 289 | 2 | GO:0016013 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.28e-03 | 16 | 289 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | DAB1 DAB2 ADGRV1 RYR1 DDX6 ITPR3 NELL1 DST RAB4B FGFR1 KIF5A RAB4A RANGAP1 ANK2 CNTRL SH3GL2 SYT6 LMTK2 WBP2NL COPS3 CCIN RAD50 LNPEP TLR4 GSDMA | 1.29e-03 | 934 | 289 | 25 | GO:0048471 |
| GeneOntologyCellularComponent | myosin complex | 1.33e-03 | 59 | 289 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | motile cilium | PGK2 DNAH14 DDX6 FSIP2 DNAH5 DNAH8 DNAH3 DNAH10 PCDH11Y DNAH2 WBP2NL DNAH7 DNAH1 | 1.41e-03 | 355 | 289 | 13 | GO:0031514 |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.42e-03 | 230 | 289 | 10 | GO:0098562 | |
| GeneOntologyCellularComponent | basement membrane | 1.55e-03 | 122 | 289 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.85e-03 | 5 | 289 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | perinuclear theca | 1.85e-03 | 5 | 289 | 2 | GO:0033011 | |
| GeneOntologyCellularComponent | CLOCK-BMAL transcription complex | 1.85e-03 | 5 | 289 | 2 | GO:1990513 | |
| MousePheno | increased circulating progesterone level | 9.10e-08 | 15 | 234 | 6 | MP:0005186 | |
| MousePheno | hypermyelination | 5.36e-07 | 11 | 234 | 5 | MP:0010050 | |
| MousePheno | abnormal parturition | 9.93e-07 | 33 | 234 | 7 | MP:0002907 | |
| MousePheno | parturition failure | 1.48e-05 | 10 | 234 | 4 | MP:0012010 | |
| MousePheno | abnormal proamniotic cavity morphology | 4.13e-05 | 24 | 234 | 5 | MP:0011197 | |
| MousePheno | increased oligodendrocyte number | 4.86e-05 | 13 | 234 | 4 | MP:0010160 | |
| MousePheno | small proamniotic cavity | 8.92e-05 | 6 | 234 | 3 | MP:0011208 | |
| MousePheno | long stride length | 9.04e-05 | 15 | 234 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 9.04e-05 | 15 | 234 | 4 | MP:0002293 | |
| MousePheno | decreased vocalization | 1.10e-04 | 46 | 234 | 6 | MP:0020351 | |
| MousePheno | abnormal fourth pharyngeal arch artery morphology | 1.53e-04 | 17 | 234 | 4 | MP:0006354 | |
| MousePheno | enlarged nasal bone | 1.54e-04 | 7 | 234 | 3 | MP:0004474 | |
| MousePheno | abnormal ear shape | 1.54e-04 | 7 | 234 | 3 | MP:0000022 | |
| MousePheno | abnormal hearing electrophysiology | MYH1 MYO1D GAS2 SCRN1 GRXCR1 AKR1C4 ADGRV1 CEP128 AKR1C1 PTGS1 AKR1C2 NFKB1 FER FGFR1 KIF5A TBX1 COL11A1 CHD7 ECT2 SLC12A2 PRAMEF14 IFFO2 AKR1C3 | 1.62e-04 | 594 | 234 | 23 | MP:0006335 |
| MousePheno | abnormal circulating progesterone level | 1.77e-04 | 50 | 234 | 6 | MP:0005184 | |
| MousePheno | abnormal gestational length | 1.95e-04 | 18 | 234 | 4 | MP:0002292 | |
| MousePheno | abnormal hearing physiology | MYH1 MYO1D GAS2 SCRN1 GRXCR1 AKR1C4 ADGRV1 CEP128 AKR1C1 PTGS1 AKR1C2 NFKB1 FER FGFR1 KIF5A DNAH5 TBX1 COL11A1 CHD7 ECT2 SLC12A2 PRAMEF14 IFFO2 AKR1C3 | 2.02e-04 | 643 | 234 | 24 | MP:0001963 |
| MousePheno | abnormal muscle fiber mitochondrial morphology | 2.04e-04 | 33 | 234 | 5 | MP:0014342 | |
| MousePheno | abnormal progesterone level | 2.72e-04 | 54 | 234 | 6 | MP:0011384 | |
| MousePheno | abnormal auditory brainstem response | MYH1 MYO1D GAS2 SCRN1 GRXCR1 AKR1C4 ADGRV1 CEP128 AKR1C1 PTGS1 AKR1C2 FER FGFR1 KIF5A TBX1 COL11A1 CHD7 ECT2 SLC12A2 PRAMEF14 IFFO2 AKR1C3 | 2.73e-04 | 576 | 234 | 22 | MP:0004738 |
| MousePheno | abnormal maxillary-premaxillary suture morphology | 2.79e-04 | 2 | 234 | 2 | MP:0014051 | |
| MousePheno | dysmyelination | 3.00e-04 | 20 | 234 | 4 | MP:0013438 | |
| Domain | Dynein_heavy_chain_D4_dom | 8.95e-14 | 14 | 291 | 9 | IPR024317 | |
| Domain | Dynein_HC_stalk | 8.95e-14 | 14 | 291 | 9 | IPR024743 | |
| Domain | MT | 8.95e-14 | 14 | 291 | 9 | PF12777 | |
| Domain | AAA_8 | 8.95e-14 | 14 | 291 | 9 | PF12780 | |
| Domain | DHC_fam | 2.21e-13 | 15 | 291 | 9 | IPR026983 | |
| Domain | Dynein_heavy | 2.21e-13 | 15 | 291 | 9 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.21e-13 | 15 | 291 | 9 | IPR004273 | |
| Domain | Dynein_heavy_dom-2 | 8.74e-12 | 14 | 291 | 8 | IPR013602 | |
| Domain | DHC_N2 | 8.74e-12 | 14 | 291 | 8 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 6.48e-10 | 14 | 291 | 7 | IPR011704 | |
| Domain | AAA_5 | 6.48e-10 | 14 | 291 | 7 | PF07728 | |
| Domain | P-loop_NTPase | MYH1 MYH4 MYH11 MYO1D ABCA13 SRP54 KIF24 DNAH14 DDX6 HELB RAB4B DDX50 HFM1 KIF5A ATL2 DNAH5 DNAH8 RAB4A DYNC1H1 GNL3 MPP7 KIF11 DNAH3 DNAH10 KIF26B DNAH2 MYO18A TWNK DDX56 CHD7 ARHGAP35 RFC5 DNAH7 DNAH1 RAD50 ABCA6 SMC3 GET3 RAB37 | 1.38e-09 | 848 | 291 | 39 | IPR027417 |
| Domain | DHC_N1 | 4.78e-08 | 8 | 291 | 5 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 4.78e-08 | 8 | 291 | 5 | IPR013594 | |
| Domain | - | ABCA13 SRP54 DNAH14 DDX6 HELB RAB4B DDX50 HFM1 ATL2 DNAH5 DNAH8 RAB4A DYNC1H1 GNL3 MPP7 DNAH3 DNAH10 DNAH2 MYO18A TWNK DDX56 CHD7 ARHGAP35 RFC5 DNAH7 DNAH1 RAD50 ABCA6 SMC3 GET3 RAB37 | 7.08e-07 | 746 | 291 | 31 | 3.40.50.300 |
| Domain | EF_hand_dom | CAPN9 NCALD ZZEF1 RYR1 RYR2 HPCA DST HPCAL1 PLS3 SCGN DNAH7 GUCA1C CGREF1 PLCH2 ANKEF1 MICU2 | 7.76e-07 | 232 | 291 | 16 | IPR002048 |
| Domain | RIH_assoc-dom | 8.45e-07 | 6 | 291 | 4 | IPR013662 | |
| Domain | Ins145_P3_rec | 8.45e-07 | 6 | 291 | 4 | PF08709 | |
| Domain | RIH_assoc | 8.45e-07 | 6 | 291 | 4 | PF08454 | |
| Domain | RIH_dom | 8.45e-07 | 6 | 291 | 4 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.45e-07 | 6 | 291 | 4 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.45e-07 | 6 | 291 | 4 | IPR015925 | |
| Domain | - | 8.45e-07 | 6 | 291 | 4 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 8.45e-07 | 6 | 291 | 4 | PF01365 | |
| Domain | EFh | CAPN9 NCALD ZZEF1 RYR2 HPCA DST HPCAL1 PLS3 SCGN GUCA1C CGREF1 PLCH2 MICU2 | 1.20e-06 | 158 | 291 | 13 | SM00054 |
| Domain | Glyco_hydro_15/PHK | 3.74e-06 | 3 | 291 | 3 | IPR011613 | |
| Domain | PHK_A/B_su | 3.74e-06 | 3 | 291 | 3 | IPR008734 | |
| Domain | Glyco_hydro_15 | 3.74e-06 | 3 | 291 | 3 | PF00723 | |
| Domain | EF-hand_1 | CAPN9 NCALD RYR2 HPCA DST HPCAL1 PLS3 SCGN GUCA1C CGREF1 PLCH2 MICU2 | 4.77e-06 | 152 | 291 | 12 | PF00036 |
| Domain | MIR | 1.13e-05 | 10 | 291 | 4 | PF02815 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.13e-05 | 10 | 291 | 4 | PS00798 | |
| Domain | MIR_motif | 1.13e-05 | 10 | 291 | 4 | IPR016093 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.13e-05 | 10 | 291 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.13e-05 | 10 | 291 | 4 | PS00063 | |
| Domain | MIR | 1.13e-05 | 10 | 291 | 4 | PS50919 | |
| Domain | MIR | 1.13e-05 | 10 | 291 | 4 | SM00472 | |
| Domain | Aldo/ket_reductase_CS | 1.13e-05 | 10 | 291 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.13e-05 | 10 | 291 | 4 | IPR020471 | |
| Domain | EF-hand_8 | 1.27e-05 | 34 | 291 | 6 | PF13833 | |
| Domain | - | CAPN9 NCALD ZZEF1 RYR1 RYR2 HPCA DST HPCAL1 PLS3 SCGN GUCA1C CGREF1 PLCH2 ANKEF1 MICU2 | 1.58e-05 | 261 | 291 | 15 | 1.10.238.10 |
| Domain | AAA | ABCA13 SRP54 DNAH5 DNAH8 DYNC1H1 DNAH3 DNAH10 DNAH2 RFC5 DNAH7 ABCA6 | 1.62e-05 | 144 | 291 | 11 | SM00382 |
| Domain | AAA+_ATPase | ABCA13 SRP54 DNAH5 DNAH8 DYNC1H1 DNAH3 DNAH10 DNAH2 RFC5 DNAH7 ABCA6 | 1.62e-05 | 144 | 291 | 11 | IPR003593 |
| Domain | EF_HAND_2 | CAPN9 NCALD ZZEF1 RYR2 HPCA DST HPCAL1 PLS3 SCGN GUCA1C CGREF1 PLCH2 ANKEF1 MICU2 | 1.68e-05 | 231 | 291 | 14 | PS50222 |
| Domain | Recoverin | 3.69e-05 | 13 | 291 | 4 | IPR028846 | |
| Domain | EF-hand-dom_pair | CAPN9 NCALD ZZEF1 RYR1 RYR2 HPCA DST HPCAL1 PLS3 SCGN GUCA1C CGREF1 PLCH2 ANKEF1 MICU2 | 4.74e-05 | 287 | 291 | 15 | IPR011992 |
| Domain | EF-hand_7 | 5.37e-05 | 85 | 291 | 8 | PF13499 | |
| Domain | - | 9.06e-05 | 16 | 291 | 4 | 3.20.20.100 | |
| Domain | EF_Hand_1_Ca_BS | CAPN9 NCALD HPCA DST HPCAL1 PLS3 SCGN DNAH7 GUCA1C CGREF1 PLCH2 | 9.73e-05 | 175 | 291 | 11 | IPR018247 |
| Domain | NADP_OxRdtase_dom | 1.17e-04 | 17 | 291 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 1.17e-04 | 17 | 291 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.17e-04 | 17 | 291 | 4 | IPR001395 | |
| Domain | Myosin_tail_1 | 1.49e-04 | 18 | 291 | 4 | PF01576 | |
| Domain | Myosin_tail | 1.49e-04 | 18 | 291 | 4 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.86e-04 | 19 | 291 | 4 | IPR027401 | |
| Domain | - | 1.86e-04 | 19 | 291 | 4 | 4.10.270.10 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.98e-04 | 8 | 291 | 3 | IPR019565 | |
| Domain | Nuc_translocat | 1.98e-04 | 8 | 291 | 3 | IPR001067 | |
| Domain | Thiol-ester_cl | 1.98e-04 | 8 | 291 | 3 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.98e-04 | 8 | 291 | 3 | IPR019742 | |
| Domain | PGLYCERATE_KINASE | 2.42e-04 | 2 | 291 | 2 | PS00111 | |
| Domain | Phosphoglycerate_kinase_N | 2.42e-04 | 2 | 291 | 2 | IPR015824 | |
| Domain | - | 2.42e-04 | 2 | 291 | 2 | 3.40.50.1270 | |
| Domain | - | 2.42e-04 | 2 | 291 | 2 | 3.40.50.1260 | |
| Domain | PGK | 2.42e-04 | 2 | 291 | 2 | PF00162 | |
| Domain | Phosphoglycerate_kinase_CS | 2.42e-04 | 2 | 291 | 2 | IPR015911 | |
| Domain | Phosphoglycerate_kinase_C | 2.42e-04 | 2 | 291 | 2 | IPR015901 | |
| Domain | FAM21 | 2.42e-04 | 2 | 291 | 2 | IPR027308 | |
| Domain | Myosin_head_motor_dom | 2.92e-04 | 38 | 291 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.92e-04 | 38 | 291 | 5 | PS51456 | |
| Domain | Myosin_head | 2.92e-04 | 38 | 291 | 5 | PF00063 | |
| Domain | MYSc | 2.92e-04 | 38 | 291 | 5 | SM00242 | |
| Domain | Calx_beta | 2.93e-04 | 9 | 291 | 3 | IPR003644 | |
| Domain | Calx-beta | 2.93e-04 | 9 | 291 | 3 | PF03160 | |
| Domain | A2M | 4.14e-04 | 10 | 291 | 3 | PF00207 | |
| Domain | A2M_N_2 | 4.14e-04 | 10 | 291 | 3 | IPR011625 | |
| Domain | A2M_comp | 4.14e-04 | 10 | 291 | 3 | IPR011626 | |
| Domain | A2M_recep | 4.14e-04 | 10 | 291 | 3 | PF07677 | |
| Domain | A2M_comp | 4.14e-04 | 10 | 291 | 3 | PF07678 | |
| Domain | A2M_N | 4.14e-04 | 10 | 291 | 3 | PF01835 | |
| Domain | A2M_N | 4.14e-04 | 10 | 291 | 3 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 4.14e-04 | 10 | 291 | 3 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 4.14e-04 | 10 | 291 | 3 | PS00477 | |
| Domain | A2M_N_2 | 4.14e-04 | 10 | 291 | 3 | PF07703 | |
| Domain | Macroglobln_a2 | 4.14e-04 | 10 | 291 | 3 | IPR001599 | |
| Domain | CH | 5.19e-04 | 65 | 291 | 6 | SM00033 | |
| Domain | Ryanodine_rcpt | 7.18e-04 | 3 | 291 | 2 | IPR003032 | |
| Domain | CAP-ZIP_m | 7.18e-04 | 3 | 291 | 2 | PF15255 | |
| Domain | Phosphoglycerate_kinase | 7.18e-04 | 3 | 291 | 2 | IPR001576 | |
| Domain | InsP3_rcpt-bd | 7.18e-04 | 3 | 291 | 2 | IPR000493 | |
| Domain | Ryanrecept_TM4-6 | 7.18e-04 | 3 | 291 | 2 | IPR009460 | |
| Domain | FAM21/CAPZIP | 7.18e-04 | 3 | 291 | 2 | IPR029341 | |
| Domain | RyR | 7.18e-04 | 3 | 291 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 7.18e-04 | 3 | 291 | 2 | PF06459 | |
| Domain | Ryan_recept | 7.18e-04 | 3 | 291 | 2 | IPR013333 | |
| Domain | MATH | 7.42e-04 | 12 | 291 | 3 | PS50144 | |
| Domain | MATH/TRAF_dom | 7.42e-04 | 12 | 291 | 3 | IPR002083 | |
| Domain | MATH | 7.42e-04 | 12 | 291 | 3 | SM00061 | |
| Domain | MATH | 7.42e-04 | 12 | 291 | 3 | PF00917 | |
| Domain | CH | 7.72e-04 | 70 | 291 | 6 | PF00307 | |
| Domain | IQ | 8.33e-04 | 71 | 291 | 6 | PF00612 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 6.01e-08 | 15 | 220 | 6 | MM14870 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.40e-07 | 27 | 220 | 7 | M47755 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 3.79e-07 | 11 | 220 | 5 | M47812 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 1.58e-06 | 14 | 220 | 5 | M46449 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 4.10e-06 | 43 | 220 | 7 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 5.62e-06 | 45 | 220 | 7 | M47670 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 6.84e-06 | 9 | 220 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 6.84e-06 | 9 | 220 | 4 | M47817 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.37e-05 | 23 | 220 | 5 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 3.70e-05 | 13 | 220 | 4 | MM14747 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 3.70e-05 | 13 | 220 | 4 | M17842 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 4.37e-05 | 61 | 220 | 7 | MM14861 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 5.11e-05 | 14 | 220 | 4 | M19193 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 5.11e-05 | 14 | 220 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 5.11e-05 | 14 | 220 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 5.11e-05 | 14 | 220 | 4 | MM14748 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 5.11e-05 | 14 | 220 | 4 | MM15391 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 6.61e-05 | 45 | 220 | 6 | M39355 | |
| Pathway | PID_RHOA_REG_PATHWAY | 7.50e-05 | 46 | 220 | 6 | M68 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 1.49e-04 | 18 | 220 | 4 | MM15577 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.86e-04 | 19 | 220 | 4 | M47760 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 1.86e-04 | 19 | 220 | 4 | M22005 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.07e-04 | 55 | 220 | 6 | M14933 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 4.05e-04 | 23 | 220 | 4 | MM14741 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 4.05e-04 | 23 | 220 | 4 | M1926 | |
| Pathway | REACTOME_DRUG_ADME | 5.51e-04 | 119 | 220 | 8 | MM15692 | |
| Pathway | WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS | 5.64e-04 | 11 | 220 | 3 | M39749 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 5.64e-04 | 25 | 220 | 4 | M27857 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 5.85e-04 | 44 | 220 | 5 | M499 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 6.50e-04 | 45 | 220 | 5 | MM14751 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 7.43e-04 | 12 | 220 | 3 | MM15616 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 AARS1 TRAF1 MYO1D TRIO GARS1 CKAP5 TFG PGK1 GTF3C3 DDX6 FAF2 DDX50 XPO5 SERPINB12 GLS PWP2 NCAPD2 MKI67 USP7 ANP32E ATL2 DNAH5 GCN1 PLS3 DYNC1H1 GNL3 SDHA KIF11 PTCD3 NPAS2 IPO5 RANGAP1 DNAH10 DDX56 COPS3 RFC5 ECHS1 CBR1 ARCN1 POLR3A RAD50 SART1 EEF1B2 THADA SMC3 CCT8 | 1.99e-15 | 1425 | 297 | 47 | 30948266 |
| Pubmed | EPRS1 MYH1 MYH4 MYH11 NCALD MYO1D PSMA2 GARS1 CEP128 PGK1 PGK2 RYR2 HPCA DST PXDN DDX50 NRXN1 HPCAL1 GLS PWP2 NCAPD2 FGFR1 KIF5A MCF2L DNAH8 TBX1 KIF11 KPNA4 PTBP3 RANGAP1 ANK2 KRT34 CNTRL DNAH2 MYO18A TWNK SPG11 SART1 EEF1B2 C2CD3 TBC1D31 KIAA0825 FAM50A CEP83 CEP295 | 6.02e-14 | 1442 | 297 | 45 | 35575683 | |
| Pubmed | 7.39e-14 | 14 | 297 | 8 | 9373155 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 AARS1 PSMA2 GARS1 CKAP5 SRP54 MCM10 MELK PGK1 GTF3C3 DDX6 DST FAF2 DDX50 SERPINB12 GLS A2ML1 NCAPD2 MKI67 USP7 MGA GCN1 DYNC1H1 GNL3 KIF11 PARP12 PTCD3 RANGAP1 DDX56 CHD7 COPS3 RFC5 ECT2 CBR1 ARCN1 POLR3A RAD50 SART1 EEF1B2 SMC3 MAP4K5 CCT8 GSDMA | 1.26e-13 | 1353 | 297 | 43 | 29467282 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 AARS1 PSMA2 GARS1 CKAP5 TFG PGK1 GTF3C3 PHKA1 PHKA2 PHKB DST XPO5 NCAPD2 USP7 ANP32E NMT1 GCN1 PLS3 DYNC1H1 GNL3 KIF11 PTCD3 KPNA4 IPO5 RANGAP1 MYO18A COPS3 ECHS1 CBR1 ARCN1 RAD50 EEF1B2 PPT1 SMC3 P4HA1 GET3 CCT8 | 1.18e-12 | 1149 | 297 | 38 | 35446349 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MYO1D TRIO DIS3L CKAP5 NEDD1 WASHC2A CEP128 CEP350 PHKB MRTFB NFKB1 PXN NMT1 MGA PLS3 DYNC1H1 GNL3 RANGAP1 FAM184A WASHC2C CNTRL SH3GL2 STIL RFC5 DNAH7 ARCN1 RAD50 C2CD3 TBC1D31 IFFO2 CCT8 CEP295 | 3.20e-12 | 853 | 297 | 32 | 28718761 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 MYO1D RBM12B CKAP5 TFG PGK1 DDX6 ITPR2 ITPR3 CEP350 DST DDX50 SERPINB12 PWP2 MKI67 MGA GCN1 DYNC1H1 GNL3 IPO5 RANGAP1 KRT82 DDX56 RFC5 ECHS1 CBR1 ARCN1 RAD50 SART1 EEF1B2 SLC12A2 SMC3 GET3 CCT8 XPO7 | 3.97e-12 | 1024 | 297 | 35 | 24711643 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 MYH1 MYH4 GARS1 OBSCN CKAP5 LRRC70 ZZEF1 FAM186B PTGS1 DNAH14 RYR1 ITPR2 FREM2 DST ANP32E DYNC1H1 SDHA DNAH3 RANGAP1 KIF26B DNAH2 LAMB3 ECT2 ARCN1 P4HA1 CCDC87 CCT8 CEP295 | 1.10e-11 | 736 | 297 | 29 | 29676528 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPRS1 AARS1 CKAP5 DAB2 NCAPH2 PGK1 XPO5 NCAPD2 USP7 GCN1 DYNC1H1 KIF11 RANGAP1 WASHC2C RFC5 CHAMP1 RAD50 SART1 SMC3 P4HA1 | 1.25e-11 | 332 | 297 | 20 | 32786267 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 MYO1D RBM12B GARS1 CKAP5 LRCH1 PGK1 GTF3C3 DDX6 ITPR2 ITPR3 DST DDX50 SERPINB12 GLS PWP2 MKI67 USP7 NMT1 PLS3 DYNC1H1 GNL3 SDHA KIF11 PTCD3 MYO18A LAMB3 DDX56 RFC5 ECT2 ARCN1 RAD50 SART1 EEF1B2 SMC3 CCT8 GSDMA MICU2 | 1.69e-11 | 1257 | 297 | 38 | 36526897 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 AARS1 MYH11 PSMA2 GARS1 ZZEF1 TFG AKR1C1 AKR1C2 PGK1 RYR1 DDX6 DST FAF2 USP7 NMT1 GCN1 DYNC1H1 IPO5 CNTRL COPS3 ECHS1 ARCN1 DNAH1 EEF1B2 SLC12A2 AKR1C3 CCT8 ZFHX3 ARHGAP18 | 1.99e-11 | 807 | 297 | 30 | 30575818 |
| Pubmed | USP34 CDC42EP4 PEX14 MCM10 TFG PGK1 GTF3C3 RYR2 CEP350 DST FAF2 DDX50 MKI67 MGA GCN1 DYNC1H1 PTCD3 DSCAM CNTRL DNAH7 ARCN1 SART1 THADA SLC12A2 IFFO2 CCT8 ZFHX3 ANO3 XPO7 | 3.99e-11 | 777 | 297 | 29 | 35844135 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | AARS1 GARS1 CKAP5 SRP54 PEX14 TFG PGK1 MRTFB FAF2 SERPINB12 NFKB1 A2ML1 NCAPD2 ANP32E PARP9 TAGLN ATL2 NMT1 GCN1 KIF11 AMPD1 RANGAP1 RANBP3 MYO18A COPS3 RFC5 ECHS1 CHAMP1 CBR1 ARCN1 IWS1 RAD50 EEF1B2 P4HA1 FAM50A GET3 CCT8 GSDMA XPO7 | 4.94e-11 | 1367 | 297 | 39 | 32687490 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | EPRS1 MYH1 MYH4 AARS1 MYH11 MYO1D PSMA2 GARS1 PGK1 PXDN FAF2 SERPINB12 NCAPD2 DYNC1H1 SDHA PTCD3 MYO18A LAMB3 RFC5 CBR1 ARCN1 EEF1B2 THADA CCT8 GSDMA SERPINC1 | 8.83e-11 | 647 | 297 | 26 | 26618866 |
| Pubmed | USP34 AARS1 MYO1D CKAP5 PGK1 GTF3C3 ITPR3 DST XPO5 PWP2 NCAPD2 MKI67 USP7 GCN1 DYNC1H1 GNL3 SDHA PTCD3 IPO5 COL5A1 RANGAP1 DDX56 CHD7 RAD50 SART1 XPO7 | 1.08e-10 | 653 | 297 | 26 | 22586326 | |
| Pubmed | EPRS1 AARS1 MAN2A1 CKAP5 PEX14 NCAPH2 MELK PGK1 DDX6 ITPR2 ITPR3 CEP350 DDX50 INTS2 NCAPD2 MKI67 PARP9 KIF5A ATL2 GCN1 DYNC1H1 GNL3 KIF11 IPO5 CNTRL MYO18A EI24 DDX56 RBM23 ARCN1 POLR3A RAD50 PPT1 P4HA1 LNPEP | 1.44e-10 | 1168 | 297 | 35 | 19946888 | |
| Pubmed | USP34 PSMA2 DAB2 PEX14 DDX6 ITPR2 ITPR3 DST PXDN FAF2 COMMD1 DDX50 XPO5 TELO2 NFKB1 NCAPD2 MKI67 USP7 ANP32E GCN1 PLS3 DYNC1H1 SDHA PARP12 PTCD3 IPO5 COL5A1 RANGAP1 EI24 DDX56 COPS3 RFC5 ARCN1 POLR3A IWS1 RAD50 EEF1B2 THADA CCT8 | 2.24e-10 | 1440 | 297 | 39 | 30833792 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 AARS1 CKAP5 SRP54 PEX14 NEDD1 PGK1 MRTFB DST DDX50 MKI67 USP7 ANP32E NMT1 GCN1 GNL3 KIF11 PARP12 EHBP1 RANGAP1 WASHC2C ANK2 RANBP3 ARHGAP35 CHAMP1 ARCN1 RAD50 EEF1B2 FAM50A CCT8 | 6.57e-10 | 934 | 297 | 30 | 33916271 |
| Pubmed | MAN2A1 CKAP5 SRP54 DDX6 MRTFB DST PXDN DDX50 INTS2 PWP2 NCAPD2 USP7 PXN NMT1 TAF1L PLS3 GNL3 SDHA MPP7 PTCD3 KPNA4 SUPT3H FAM184A TWNK DDX56 CHD7 RFC5 ECT2 RBM23 IWS1 EEF1B2 SLC12A2 P4HA1 LNPEP CGREF1 CEP83 CCT8 ZFHX3 MICU2 | 6.77e-10 | 1497 | 297 | 39 | 31527615 | |
| Pubmed | EPRS1 MYH11 GARS1 DAB1 SRP54 TFG AKR1C1 AKR1C2 PGK1 GTF3C3 DDX6 CEP350 CACTIN SERPINB12 MKI67 C4B NMT1 GCN1 PLS3 DYNC1H1 GNL3 PARP12 PTCD3 PTBP3 RC3H2 COL11A1 ANK2 RBM45 DDX56 CHD7 ECHS1 RBM23 ARCN1 P4HA1 FAM50A AKR1C3 CCT8 | 7.48e-10 | 1371 | 297 | 37 | 36244648 | |
| Pubmed | 9.09e-10 | 7 | 297 | 5 | 9256245 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | USP34 EPRS1 AARS1 PSMA2 GARS1 GTF3C3 DDX6 PHKA2 FAF2 XPO5 TELO2 A2ML1 NCAPD2 USP7 GCN1 PLS3 DYNC1H1 SDHA KPNA4 RANGAP1 COPS3 ARCN1 RAD50 | 1.07e-09 | 571 | 297 | 23 | 37167062 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 MYH11 GIN1 PSMA2 CKAP5 PGK1 PGK2 DDX6 NCAPD2 KIF5A PLS3 DYNC1H1 SDHA PTCD3 PTBP3 DNAH3 RANGAP1 DNAH2 RFC5 ARCN1 POLR3A RAD50 SART1 EEF1B2 SMC3 FAM50A GET3 CCT8 | 1.34e-09 | 847 | 297 | 28 | 35235311 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CKAP5 SRP54 MELK DDX6 HSPA12A XPO5 NCAPD2 GCN1 DYNC1H1 KIF11 IPO5 PTBP3 RANGAP1 RBM45 CHD7 COPS3 RFC5 ECT2 ARCN1 RAD50 SART1 SMC3 CCT8 | 1.54e-09 | 582 | 297 | 23 | 20467437 |
| Pubmed | 2.41e-09 | 8 | 297 | 5 | 33584538 | ||
| Pubmed | PSMA2 CKAP5 SRP54 PEX14 WASHC2A MRTFB FAF2 TELO2 NCAPD2 GCN1 KIF11 IPO5 EHBP1 RANGAP1 ANK2 ARCN1 SLC12A2 LNPEP CCT8 APPL1 | 2.50e-09 | 449 | 297 | 20 | 31732153 | |
| Pubmed | PSMA2 GTF3C3 DDX6 CEP350 DST DDX50 FER USP7 MGA GNL3 SDHA PTCD3 IPO5 RC3H2 RANGAP1 COPS3 RFC5 CHAMP1 ECT2 SART1 SMC3 FAM50A | 2.57e-09 | 547 | 297 | 22 | 37267103 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | EPRS1 MYH4 MYH11 TRIO CKAP5 ITPR3 PHKB PXDN TMTC3 XPO5 NCAPD2 GCN1 IPO5 MYO18A | 2.62e-09 | 202 | 297 | 14 | 33005030 |
| Pubmed | USP34 SRP54 WASHC2A INTS2 XPO5 NCAPD2 USP7 ANP32E GCN1 KPNA4 IPO5 RANGAP1 CHD7 COPS3 CLOCK SMC3 | 3.46e-09 | 282 | 297 | 16 | 23667531 | |
| Pubmed | USP34 AARS1 PSMA2 SRP54 AKR1C1 AKR1C2 PGK1 GTF3C3 CACTIN XPO5 PWP2 NCAPD2 MKI67 USP7 ANP32E GNL3 IPO5 RFC5 CHAMP1 CBR1 POLR3A IWS1 RAD50 SART1 EEF1B2 SMC3 FAM50A AKR1C3 CCT8 XPO7 | 4.37e-09 | 1014 | 297 | 30 | 32416067 | |
| Pubmed | EPRS1 NCALD TRIO CKAP5 SCRN1 WASHC2A PGK1 STX1B RYR2 HPCA HSPA12A NRXN1 HPCAL1 GLS USP7 GCN1 SDHA PTCD3 EHBP1 RANGAP1 WASHC2C ANK2 SH3GL2 MYO18A LMTK2 PANX2 ARHGAP35 ECHS1 ARCN1 EEF1B2 CCT8 APPL1 | 4.46e-09 | 1139 | 297 | 32 | 36417873 | |
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 10393440 | ||
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 5.21e-09 | 4 | 297 | 4 | 31479646 | |
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 10702227 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 17442338 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 28329705 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 16511129 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 15222881 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 10526179 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 21521174 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 8274401 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 5.21e-09 | 4 | 297 | 4 | 34590152 | |
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 5.21e-09 | 4 | 297 | 4 | 10500239 | |
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 5.21e-09 | 4 | 297 | 4 | 14967952 | |
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 5.21e-09 | 4 | 297 | 4 | 15193432 | |
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 16191478 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 3472241 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 15577209 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 5.21e-09 | 4 | 297 | 4 | 29764944 | |
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 17888864 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 19237748 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 28259989 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 7789999 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 5.21e-09 | 4 | 297 | 4 | 16508162 | |
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 17629694 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 16018803 | ||
| Pubmed | 5.21e-09 | 4 | 297 | 4 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 5.21e-09 | 4 | 297 | 4 | 18667791 | |
| Pubmed | EPRS1 MYO1D PSMA2 GARS1 TFG GTF3C3 DDX6 USP7 PLS3 PTCD3 KPNA4 PTBP3 RANGAP1 LAMB3 DDX56 CBR1 ARCN1 SART1 SMC3 P4HA1 | 5.22e-09 | 469 | 297 | 20 | 37314180 | |
| Pubmed | 5.38e-09 | 9 | 297 | 5 | 33348080 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | EPRS1 GARS1 CKAP5 PGK1 RYR1 ITPR2 SERPINB12 A2ML1 USP7 C4A GCN1 PLS3 GNL3 PTBP3 COL11A1 TWNK DDX56 RFC5 CBR1 EEF1B2 C2CD3 PPT1 P4HA1 CCT8 SERPINC1 | 5.61e-09 | 732 | 297 | 25 | 34732716 |
| Pubmed | USP34 AARS1 TRIO MCM10 NEDD1 WASHC2A TFG MELK ITPR2 CEP350 TMTC3 CTNNBIP1 ATL2 MGA GNL3 GCFC2 EI24 ARHGEF18 SPG11 CHD7 TBC1D31 SLC12A2 P4HA1 DDHD1 CEP295 | 5.77e-09 | 733 | 297 | 25 | 34672954 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPRS1 MYH4 MYO1D PSMA2 GTF3C3 DDX6 CACTIN FAF2 XPO5 TELO2 CTNNBIP1 USP7 TAGLN GCN1 PLS3 DYNC1H1 GNL3 PTCD3 KPNA4 RANGAP1 KRT34 KRT82 RANBP3 DDX56 COPS3 RFC5 ECHS1 CBR1 RAD50 EEF1B2 RADIL SMC3 KRT36 XPO7 | 6.22e-09 | 1284 | 297 | 34 | 17353931 |
| Pubmed | CDC42EP4 CKAP5 MCM10 GTF3C3 TELO2 ANP32E TAF1L GCN1 KIF11 IPO5 EHBP1 RANGAP1 ARHGEF18 RFC5 POLR3A SART1 CCDC87 CCT8 | 9.23e-09 | 390 | 297 | 18 | 17643375 | |
| Pubmed | MYT1L USP34 SCRN1 ADGRV1 LRCH1 ZNF518A MRTFB DST NRXN1 XPO5 GCN1 CHD7 ARHGAP35 APPL1 | 1.04e-08 | 225 | 297 | 14 | 12168954 | |
| Pubmed | MYT1L USP34 EPRS1 OBSCN SRP54 AKR1C4 WASHC2A AKR1C1 AKR1C2 F13A1 PHKB DDX50 INTS2 NMT1 MGA KIF11 PARP12 ZNF821 WASHC2C CNTRL LMTK2 ARHGEF18 CHD7 TBC1D31 TCP11L2 PRAMEF14 DDHD1 TLR4 AKR1C3 CEP295 | 1.96e-08 | 1084 | 297 | 30 | 11544199 | |
| Pubmed | EPRS1 AARS1 GARS1 GTF3C3 FAF2 NCAPD2 GCN1 DYNC1H1 GNL3 SDHA RANGAP1 RAD50 SMC3 CCT8 | 2.02e-08 | 237 | 297 | 14 | 29564676 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPRS1 AARS1 GARS1 CKAP5 TFG PGK1 DDX6 FAF2 NCAPD2 USP7 ANP32E NMT1 GCN1 PLS3 DYNC1H1 GNL3 SDHA KIF11 PTCD3 KPNA4 IPO5 RANGAP1 KRT34 ARHGAP35 RFC5 CHAMP1 CBR1 ARCN1 IWS1 RAD50 SART1 EEF1B2 SMC3 FAM50A CCT8 | 2.02e-08 | 1415 | 297 | 35 | 28515276 |
| Pubmed | 2.59e-08 | 5 | 297 | 4 | 7737980 | ||
| Pubmed | 2.59e-08 | 5 | 297 | 4 | 38788959 | ||
| Pubmed | 2.59e-08 | 5 | 297 | 4 | 18003893 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 2.59e-08 | 5 | 297 | 4 | 21851338 | |
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 2.59e-08 | 5 | 297 | 4 | 16984997 | |
| Pubmed | 2.59e-08 | 5 | 297 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 2.59e-08 | 5 | 297 | 4 | 17064890 | |
| Pubmed | 2.59e-08 | 5 | 297 | 4 | 10672042 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 LZTR1 TRIO OBSCN ZZEF1 WASHC2A RYR1 ITPR2 ITPR3 DST NCAPD2 USP7 PXN FGFR1 TAGLN MCF2L GCN1 DYNC1H1 SDHA SLC35B3 KAT6A LMTK2 LAMB3 TWNK DDX56 ARHGAP35 CPTP RADIL THADA C2CD3 | 2.99e-08 | 1105 | 297 | 30 | 35748872 |
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 3.31e-08 | 12 | 297 | 5 | 21256921 | |
| Pubmed | 3.31e-08 | 12 | 297 | 5 | 25774556 | ||
| Pubmed | LZTR1 MYO1D TRIO PPM1H ITPR2 ITPR3 CEP350 PHKA1 PHKB CACTIN HSPA12A DDX50 TELO2 NFKB1 MKI67 USP7 PXN GCN1 MPP7 KPNA4 RANGAP1 LMTK2 IWS1 C2CD3 TBC1D31 SLC12A2 P4HA1 LNPEP L3MBTL3 | 3.50e-08 | 1049 | 297 | 29 | 27880917 | |
| Pubmed | EPRS1 MYO1D PSMA2 GARS1 PGK1 DDX6 ITPR3 CTNNBIP1 ERAP2 MKI67 USP7 PXN MGA GCN1 DYNC1H1 GNL3 SDHA PARP12 KPNA4 IPO5 PTBP3 ANKRD35 RANGAP1 RFC5 ARCN1 DNAH1 SART1 EEF1B2 PPT1 SMC3 GET3 CCT8 | 3.71e-08 | 1247 | 297 | 32 | 27684187 | |
| Pubmed | EPRS1 CKAP5 GTF3C3 DDX6 FAF2 XPO5 TELO2 PWP2 NCAPD2 USP7 GCN1 PLS3 DYNC1H1 GNL3 KIF11 IPO5 RANGAP1 ARCN1 RAD50 SMC3 CCT8 APPL1 | 4.03e-08 | 638 | 297 | 22 | 33239621 | |
| Pubmed | 5.34e-08 | 13 | 297 | 5 | 24580729 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | AARS1 PSMA2 GARS1 CKAP5 ADGRV1 WASHC2A TFG PGK1 PLS3 KIF11 IPO5 RANGAP1 COPS3 CBR1 ARCN1 EEF1B2 SMC3 P4HA1 CCT8 | 6.70e-08 | 495 | 297 | 19 | 28581483 |
| Pubmed | SRP54 WASHC2A GTF3C3 ITPR2 ITPR3 CACTIN HSPA12A FAF2 DNAJC28 TMTC3 TELO2 ERAP2 GLS PWP2 ANP32E DDHD2 PLS3 GNL3 SDHA MPP7 PTCD3 RANGAP1 FAM184A ANK2 RANBP3 MYO18A TWNK SPG11 ECHS1 THADA TBC1D31 SLC12A2 P4HA1 LNPEP MAP4K5 | 6.79e-08 | 1487 | 297 | 35 | 33957083 | |
| Pubmed | 7.71e-08 | 6 | 297 | 4 | 19273550 | ||
| Pubmed | 7.71e-08 | 6 | 297 | 4 | 15471942 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 7.71e-08 | 6 | 297 | 4 | 25966694 | |
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 7.71e-08 | 6 | 297 | 4 | 26748576 | |
| Pubmed | 7.71e-08 | 6 | 297 | 4 | 20519450 | ||
| Pubmed | 7.71e-08 | 6 | 297 | 4 | 17122075 | ||
| Pubmed | 7.71e-08 | 6 | 297 | 4 | 23463619 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 7.71e-08 | 6 | 297 | 4 | 29107092 | |
| Pubmed | 7.71e-08 | 6 | 297 | 4 | 15860270 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 7.71e-08 | 6 | 297 | 4 | 17255200 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 7.71e-08 | 6 | 297 | 4 | 16844763 | |
| Interaction | BIRC3 interactions | EPRS1 AARS1 TRAF1 MYO1D TRIO GARS1 CKAP5 TFG PGK1 GTF3C3 DDX6 FAF2 COMMD1 DDX50 XPO5 SERPINB12 NFKB1 GLS PWP2 NCAPD2 MKI67 USP7 ANP32E ATL2 DNAH5 GCN1 PLS3 DYNC1H1 GNL3 SDHA KIF11 PTCD3 IPO5 RANGAP1 DNAH10 DDX56 COPS3 RFC5 ECHS1 CBR1 ARCN1 RAD50 SART1 EEF1B2 SMC3 CCT8 | 2.33e-08 | 1334 | 288 | 46 | int:BIRC3 |
| Interaction | OFD1 interactions | GARS1 NCAPH2 MCM10 NEDD1 WASHC2A CEP128 CEP350 USP7 PXN DYNC1H1 IPO5 EHBP1 FAM184A CNTRL STIL RFC5 ECT2 RAD50 C2CD3 TBC1D31 CEP295 | 3.15e-08 | 347 | 288 | 21 | int:OFD1 |
| Interaction | EED interactions | CHL1 EPRS1 AARS1 MYH11 MAN2A1 MYO1D TRIO RBM12B GARS1 OBSCN CKAP5 DAB2 PGK1 GTF3C3 DDX6 PXDN DDX50 XPO5 PWP2 NCAPD2 TRIM55 USP7 MGA PLS3 DYNC1H1 GNL3 KIF11 KPNA4 IPO5 RANGAP1 MYO18A DDX56 CHD7 COPS3 RFC5 CBR1 ARCN1 RAD50 SART1 EEF1B2 THADA TBC1D31 SMC3 P4HA1 GET3 CCT8 XPO7 | 9.37e-08 | 1445 | 288 | 47 | int:EED |
| Interaction | SUMO2 interactions | EPRS1 AARS1 TRAF1 CKAP5 DAB2 NCAPH2 PGK1 DST XPO5 NCAPD2 MKI67 USP7 GCN1 DYNC1H1 KIF11 IPO5 ANKRD35 RANGAP1 WASHC2C RFC5 CHAMP1 NPEPL1 RAD50 SART1 SMC3 P4HA1 | 4.24e-07 | 591 | 288 | 26 | int:SUMO2 |
| Interaction | POLR1G interactions | SCRN1 GTF3C3 CACTIN DDX50 XPO5 NFKB1 PWP2 USP7 ANP32E MGA GNL3 KPNA4 IPO5 RC3H2 KAT6A DDX56 CHD7 RFC5 POLR3A IWS1 RAD50 FAM50A XPO7 | 6.47e-07 | 489 | 288 | 23 | int:POLR1G |
| Interaction | SOX2 interactions | USP34 EPRS1 GARS1 CKAP5 SRP54 WASHC2A PGK1 RYR1 ITPR2 DDX50 INTS2 XPO5 SERPINB12 A2ML1 NCAPD2 USP7 ANP32E C4A GCN1 PLS3 GNL3 PTCD3 KPNA4 IPO5 PTBP3 RANGAP1 COL11A1 TWNK DDX56 CHD7 COPS3 RFC5 CHAMP1 CLOCK CBR1 EEF1B2 C2CD3 PPT1 SMC3 P4HA1 CCT8 SERPINC1 ZFHX3 L3MBTL3 | 9.99e-07 | 1422 | 288 | 44 | int:SOX2 |
| Interaction | LRRC31 interactions | EPRS1 MYH4 MYH11 TRIO CKAP5 ITPR3 PHKB PXDN TMTC3 XPO5 NCAPD2 GCN1 IPO5 MYO18A | 1.59e-06 | 205 | 288 | 14 | int:LRRC31 |
| Interaction | AKR1C4 interactions | 2.73e-06 | 8 | 288 | 4 | int:AKR1C4 | |
| Interaction | RNF123 interactions | EPRS1 MYH1 MYH4 GARS1 OBSCN CKAP5 LRRC70 ZZEF1 FAM186B PTGS1 DNAH14 RYR1 ITPR2 FREM2 DST NFKB1 ANP32E DYNC1H1 SDHA DNAH3 RANGAP1 KIF26B DNAH2 LAMB3 ECT2 ARCN1 P4HA1 CCDC87 CCT8 CEP295 | 2.78e-06 | 824 | 288 | 30 | int:RNF123 |
| Interaction | SPICE1 interactions | GARS1 PEX14 NEDD1 CEP128 CEP350 PXN PTCD3 IPO5 FAM184A RFC5 C2CD3 TBC1D31 CEP295 | 3.91e-06 | 191 | 288 | 13 | int:SPICE1 |
| Interaction | AGR2 interactions | EPRS1 AARS1 MYH11 PSMA2 GARS1 ZZEF1 TFG AKR1C1 AKR1C2 PGK1 RYR1 DDX6 DST FAF2 USP7 NMT1 GCN1 DYNC1H1 IPO5 NTAQ1 CNTRL COPS3 ECHS1 ARCN1 DNAH1 EEF1B2 SLC12A2 GET3 AKR1C3 CCT8 ZFHX3 ARHGAP18 | 4.53e-06 | 934 | 288 | 32 | int:AGR2 |
| Interaction | NIN interactions | MYO1D TRIO CKAP5 NEDD1 CEP128 CEP350 PXN MGA DYNC1H1 FAM184A CNTRL STIL RFC5 ARCN1 C2CD3 TBC1D31 IFFO2 CEP295 | 4.58e-06 | 359 | 288 | 18 | int:NIN |
| Interaction | CDC5L interactions | MYT1L TRIO PSMA2 CKAP5 SRP54 MCM10 MELK DDX6 CACTIN HSPA12A DST XPO5 NCAPD2 TRIM55 USP7 GCN1 DYNC1H1 KIF11 IPO5 PTBP3 RC3H2 RANGAP1 RBM45 RFC5 ECT2 ARCN1 RAD50 SART1 SMC3 CCT8 | 5.77e-06 | 855 | 288 | 30 | int:CDC5L |
| Interaction | BAP1 interactions | EPRS1 AARS1 PSMA2 GARS1 CKAP5 TFG PGK1 GTF3C3 ITPR3 PHKA1 PHKA2 PHKB DST XPO5 NCAPD2 USP7 ANP32E NMT1 GCN1 PLS3 DYNC1H1 GNL3 KIF11 PTCD3 KPNA4 IPO5 RANGAP1 MYO18A COPS3 ECHS1 CBR1 ARCN1 RAD50 EEF1B2 PPT1 SMC3 P4HA1 GET3 CCT8 | 1.17e-05 | 1314 | 288 | 39 | int:BAP1 |
| Interaction | FBXL6 interactions | PSMA2 TFG GTF3C3 DDX6 CEP350 DST DDX50 FER USP7 MGA GNL3 SDHA PTCD3 IPO5 RC3H2 RANGAP1 COPS3 RFC5 CHAMP1 ECT2 SART1 SMC3 FAM50A | 1.21e-05 | 583 | 288 | 23 | int:FBXL6 |
| Interaction | DNAI2 interactions | 1.88e-05 | 80 | 288 | 8 | int:DNAI2 | |
| Interaction | MIB1 interactions | DIS3L DAB2 CEP128 XPO5 PXN MGA GCN1 SDHA RANGAP1 FAM184A CNTRL FSD1 STIL ARHGAP35 TBC1D31 | 2.44e-05 | 295 | 288 | 15 | int:MIB1 |
| Interaction | CD274 interactions | EPRS1 CKAP5 FAF2 DDX50 INTS2 TELO2 SERPINB12 USP7 NMT1 GCN1 PLS3 IPO5 EEF1B2 THADA SMC3 GSDMA XPO7 | 2.51e-05 | 369 | 288 | 17 | int:CD274 |
| Interaction | SIRT7 interactions | USP34 AARS1 MYO1D CKAP5 PGK1 GTF3C3 ITPR3 DST XPO5 PWP2 NCAPD2 MKI67 USP7 GCN1 DYNC1H1 GNL3 SDHA PTCD3 IPO5 COL5A1 RANGAP1 DDX56 CHD7 RAD50 SART1 XPO7 | 2.67e-05 | 744 | 288 | 26 | int:SIRT7 |
| Interaction | MAPT interactions | AARS1 TRIO CKAP5 SCRN1 TFG CEP128 MELK PGK1 STX1B DDX6 FSIP2 PHKG1 HSPA12A FAF2 GLS PWP2 USP7 KIF5A TAGLN NMT1 DYNC1H1 SDHA KPNA4 IPO5 RANGAP1 ANK2 FSD1 COPS3 NPEPL1 CBR1 EEF1B2 SLC12A2 SMC3 CCT8 | 2.80e-05 | 1119 | 288 | 34 | int:MAPT |
| Interaction | H3C1 interactions | EPRS1 ZKSCAN8 ZZEF1 GTF3C3 CACTIN MKI67 USP7 PXN ANP32E MGA DNAH8 DYNC1H1 GNL3 KIF11 PTCD3 IPO5 ANK2 KAT6A DNAH2 MYO18A CHD7 RFC5 CHAMP1 DNAH1 RAD50 SMC3 FAM50A ZFHX3 L3MBTL3 | 4.09e-05 | 901 | 288 | 29 | int:H3C1 |
| Interaction | KCNA3 interactions | CHL1 EPRS1 MYO1D ABCA13 CKAP5 RYR1 DDX6 DST FAF2 XPO5 NCAPD2 DNAH5 GCN1 PLS3 DYNC1H1 SDHA MPP7 KIF11 IPO5 EHBP1 RANGAP1 ANK2 MYO18A ARCN1 RAD50 SMC3 MAP4K5 CCT8 | 5.70e-05 | 871 | 288 | 28 | int:KCNA3 |
| Interaction | HAPSTR1 interactions | USP34 EPRS1 AARS1 DIS3L GARS1 CKAP5 ADGRV1 FREM2 FAF2 XPO5 TELO2 GLS NCAPD2 USP7 GCN1 PLS3 SDHA KPNA4 IPO5 RANGAP1 FAM184A COPS3 CBR1 ARCN1 RAD50 CCT8 ANO3 | 6.25e-05 | 829 | 288 | 27 | int:HAPSTR1 |
| Interaction | PRKACA interactions | CEP128 RYR1 RYR2 ITPR2 ITPR3 MEP1B PHKA1 XPO5 NFKB1 TRIM55 FGFR1 NMT1 GCN1 PLS3 DYNC1H1 IPO5 CNTRL SLC12A2 MAP4K5 CCT8 | 6.25e-05 | 519 | 288 | 20 | int:PRKACA |
| Interaction | TOP3B interactions | USP34 EPRS1 LZTR1 MYO1D TRIO OBSCN NEDD1 ZZEF1 WASHC2A RYR1 DDX6 ITPR2 ITPR3 DST XPO5 NCAPD2 USP7 PXN FGFR1 TAGLN MCF2L NMT1 GCN1 DYNC1H1 SDHA IPO5 RC3H2 SLC35B3 KAT6A LMTK2 LAMB3 TWNK DDX56 ARHGAP35 CBR1 CPTP RADIL THADA C2CD3 P4HA1 | 6.39e-05 | 1470 | 288 | 40 | int:TOP3B |
| Interaction | NAA40 interactions | EPRS1 AARS1 CKAP5 SRP54 PEX14 NEDD1 PGK1 MRTFB DST DDX50 MKI67 USP7 ANP32E NMT1 GCN1 GNL3 KIF11 PARP12 EHBP1 RANGAP1 WASHC2C ANK2 RANBP3 ARHGAP35 CHAMP1 ARCN1 RAD50 EEF1B2 FAM50A CCT8 | 7.20e-05 | 978 | 288 | 30 | int:NAA40 |
| Interaction | RPGRIP1L interactions | GARS1 WASHC2A CEP128 CEP350 DYNC1H1 SDHA CNTRL DDX56 STIL ECT2 RAD50 SMC3 | 1.01e-04 | 225 | 288 | 12 | int:RPGRIP1L |
| Interaction | CIT interactions | AARS1 MYH11 RBM12B CKAP5 SRP54 ADGRV1 ZZEF1 ITPR3 CACTIN PXDN FAF2 DDX50 XPO5 PWP2 MKI67 GCN1 PLS3 DYNC1H1 GNL3 SDHA KIF11 IPO5 PTBP3 ANKRD35 RANGAP1 DSCAM MYO18A DDX56 RFC5 CHAMP1 ECT2 RBM23 IWS1 SART1 EEF1B2 PPT1 SMC3 P4HA1 CCT8 | 1.02e-04 | 1450 | 288 | 39 | int:CIT |
| Interaction | TAFA5 interactions | 1.07e-04 | 18 | 288 | 4 | int:TAFA5 | |
| Interaction | CAPZB interactions | EPRS1 MYH11 MYO1D SRP54 WASHC2A TFG DDX6 ITPR2 ITPR3 NFKB1 MKI67 USP7 RAB4A PLS3 DYNC1H1 GNL3 IPO5 PTBP3 RC3H2 WASHC2C MYO18A ARHGEF18 COPS3 ECT2 RAD50 EEF1B2 PPT1 FAM50A CCT8 GSDMA CEP295 | 1.07e-04 | 1049 | 288 | 31 | int:CAPZB |
| Interaction | CNTRL interactions | CKAP5 NEDD1 WASHC2A CEP128 CEP350 PWP2 DYNC1H1 CNTRL ARHGEF18 C2CD3 TBC1D31 | 1.09e-04 | 193 | 288 | 11 | int:CNTRL |
| Interaction | CRY2 interactions | EPRS1 TRAF1 GARS1 USP7 GCN1 DYNC1H1 SDHA NPAS2 KPNA4 CLOCK CCT8 | 1.15e-04 | 194 | 288 | 11 | int:CRY2 |
| Interaction | ANK1 interactions | 1.44e-04 | 56 | 288 | 6 | int:ANK1 | |
| Interaction | PRC1 interactions | AARS1 RBM12B ZZEF1 ITPR2 FAF2 DDX50 XPO5 PWP2 MKI67 ANP32E GCN1 DYNC1H1 GNL3 KPNA4 PTBP3 ANKRD35 RANGAP1 MYO18A HSF2BP TWNK DDX56 SPG11 RFC5 CHAMP1 SART1 P4HA1 GET3 CEP83 CCT8 | 1.56e-04 | 973 | 288 | 29 | int:PRC1 |
| Interaction | FTL interactions | MYO1D MCM10 NEDD1 MELK DNAH14 ZNF518A MGA NTAQ1 FSD1 ARHGAP35 CHAMP1 ECT2 POLR3A TBC1D31 SMC3 | 1.57e-04 | 348 | 288 | 15 | int:FTL |
| Interaction | AKR1C1 interactions | 1.65e-04 | 20 | 288 | 4 | int:AKR1C1 | |
| Interaction | EFNA4 interactions | PXDN INTS2 XPO5 TMEM147 KRT34 KRT82 CNTRL CHD7 RSPRY1 THADA KRT36 XPO7 | 1.78e-04 | 239 | 288 | 12 | int:EFNA4 |
| Interaction | PML interactions | USP34 MYO1D SRP54 MCM10 NEDD1 PGK1 GTF3C3 ITPR2 DDX50 NFKB1 USP7 PXN PARP9 AIM2 GCN1 KPNA4 IPO5 RANGAP1 WASHC2C KAT6A ECT2 CBR1 RAD50 SART1 FAM50A GET3 CCT8 L3MBTL3 | 1.82e-04 | 933 | 288 | 28 | int:PML |
| Cytoband | 10p15-p14 | 5.28e-06 | 6 | 297 | 3 | 10p15-p14 | |
| GeneFamily | Dyneins, axonemal | 7.50e-12 | 17 | 214 | 8 | 536 | |
| GeneFamily | EF-hand domain containing | CAPN9 NCALD ZZEF1 RYR2 HPCA DST HPCAL1 PLS3 SCGN DNAH7 GUCA1C CGREF1 PLCH2 ANKEF1 MICU2 | 5.49e-08 | 219 | 214 | 15 | 863 |
| GeneFamily | Aldo-keto reductases | 2.35e-05 | 15 | 214 | 4 | 399 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.30e-04 | 9 | 214 | 3 | 1234 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 4.15e-04 | 3 | 214 | 2 | 297 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 4.15e-04 | 3 | 214 | 2 | 287 | |
| GeneFamily | Myosin heavy chains | 6.70e-04 | 15 | 214 | 3 | 1098 | |
| GeneFamily | Aminopeptidases|CD molecules | 9.84e-04 | 17 | 214 | 3 | 104 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.10e-03 | 66 | 214 | 5 | 722 | |
| GeneFamily | T-boxes | 1.17e-03 | 18 | 214 | 3 | 766 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 1.38e-03 | 19 | 214 | 3 | 132 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.44e-03 | 181 | 214 | 8 | 694 | |
| GeneFamily | WASH complex | 2.03e-03 | 6 | 214 | 2 | 1331 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.11e-03 | 46 | 214 | 4 | 622 | |
| GeneFamily | Exportins | 2.82e-03 | 7 | 214 | 2 | 547 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.10e-03 | 161 | 214 | 7 | 593 | |
| GeneFamily | CD molecules|Toll like receptors | 5.89e-03 | 10 | 214 | 2 | 948 | |
| Coexpression | GREENBAUM_E2A_TARGETS_UP | 6.76e-08 | 33 | 293 | 7 | M1490 | |
| Coexpression | GREENBAUM_E2A_TARGETS_UP | 8.43e-08 | 34 | 293 | 7 | MM1160 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | AARS1 MYH11 CKAP5 NCAPH2 MCM10 MELK MKI67 ANP32E IPO5 RFC5 ECT2 | 1.29e-06 | 153 | 293 | 11 | M5588 |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | AARS1 MYH11 CKAP5 NCAPH2 MCM10 MELK MKI67 ANP32E IPO5 RFC5 ECT2 | 1.47e-06 | 155 | 293 | 11 | MM1259 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | EPRS1 AARS1 CKAP5 MCM10 GTF3C3 NCAPD2 MKI67 GCN1 RAB4A GNL3 KIF11 IPO5 SUPT3H GCFC2 NTAQ1 TWNK DDX56 CHD7 ECT2 EEF1B2 TBC1D31 XPO7 | 1.78e-06 | 612 | 293 | 22 | M4772 |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 2.72e-06 | 36 | 293 | 6 | MM3660 | |
| Coexpression | GSE30083_SP2_VS_SP3_THYMOCYTE_UP | CHL1 NFKB1 KCNN4 C4B TAGLN TBX1 TBX22 ZNF821 ANK2 AKR1C3 SLC24A1 LRRC36 | 2.73e-06 | 199 | 293 | 12 | M5031 |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 3.22e-06 | 37 | 293 | 6 | MM630 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | AARS1 UGT3A1 DAB1 CKAP5 SRP54 MCM10 MELK PGK1 ITPR3 TMTC3 XPO5 NCAPD2 MKI67 PXN ANP32E ATL2 NMT1 KIF11 PTBP3 AMPD1 RANGAP1 GCFC2 NTAQ1 LAMB3 COPS3 RFC5 CHAMP1 ECT2 CLOCK RSPRY1 SMC3 DDHD1 APPL1 XPO7 | 3.39e-06 | 1290 | 293 | 34 | M80 |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 6.02e-06 | 24 | 293 | 5 | MM766 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | EPHX2 EPRS1 MYH1 AARS1 RYR1 ITPR3 XPO5 CTNNBIP1 MKI67 MGA RAB4A COL11A1 KRT34 KRT82 LMTK2 NPEPL1 POLR3A IFFO2 GSDMA KRT36 EPAS1 | 6.76e-06 | 615 | 293 | 21 | M8673 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 MAN2A1 TRIO CKAP5 PEX14 ZZEF1 MELK CEP350 DST HPCAL1 NFKB1 USP7 KIF11 EHBP1 KAT6A SPG11 STIL ARHGAP35 CLOCK C2CD3 TBC1D31 SMC3 MAP4K5 ZFHX3 MICU2 | 1.34e-05 | 856 | 293 | 25 | M4500 |
| Coexpression | GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP | AARS1 MYO1D TRIO DDX6 HPCAL1 SDHA MAP3K8 STIL ECHS1 RAD50 XPO7 | 1.69e-05 | 200 | 293 | 11 | M7270 |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP | GARS1 NCAPD2 TMEM147 MKI67 ANP32E GNL3 IPO5 CHD7 STIL RFC5 ECT2 | 1.69e-05 | 200 | 293 | 11 | M6553 |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | MAN2A1 SRP54 NCAPH2 TFG PGK1 NCAPD2 KCNN4 NMT1 GNL3 KIF11 SLC12A2 | 1.69e-05 | 200 | 293 | 11 | M9120 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | MAN2A1 PSMA2 GARS1 GAS2 SRP54 TFG PTGS1 PGK1 GTF3C3 ITPR2 PHKB NFKB1 PWP2 KCNN4 GMPR C4A NMT1 RAB4A GNL3 KPNA4 IPO5 PTBP3 RANGAP1 COPS3 ECHS1 ARCN1 RAD50 SMC3 P4HA1 MAP4K5 GET3 AKR1C3 CCT8 MICU2 | 1.87e-05 | 1399 | 293 | 34 | M535 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | EPRS1 MYH1 AARS1 RYR1 ITPR3 XPO5 CTNNBIP1 NCAPD2 MKI67 MGA RAB4A COL11A1 KRT34 KRT82 LMTK2 NPEPL1 POLR3A IFFO2 GSDMA KRT36 | 2.01e-05 | 610 | 293 | 20 | M3854 |
| Coexpression | GABRIELY_MIR21_TARGETS | USP34 SCRN1 USP7 PARP9 DDHD2 MGA PTBP3 CNTRL SPG11 CLOCK RSPRY1 TLR4 ANO3 | 2.51e-05 | 289 | 293 | 13 | M2196 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 2.96e-05 | 79 | 293 | 7 | MM535 | |
| Coexpression | KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP | CHL1 AARS1 LZTR1 GARS1 SCRN1 PGK1 HPCA NELL1 HSPA12A HPCAL1 TMEM147 DDHD2 DYNC1H1 SDHA MPPED1 EHBP1 ARHGEF18 ECHS1 CCT8 SNTA1 XPO7 | 3.01e-05 | 680 | 293 | 21 | M2107 |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 3.25e-05 | 17 | 293 | 4 | MM826 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | CDC42EP4 TRIO AKR1C1 HPCAL1 GLS FGFR1 GCN1 DYNC1H1 PARP12 WASHC2C DNAH2 MYO18A LMTK2 TLR4 AKR1C3 EPAS1 | 3.36e-05 | 433 | 293 | 16 | M2240 |
| Coexpression | LEE_AGING_NEOCORTEX_UP | 4.08e-05 | 83 | 293 | 7 | MM1022 | |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | CHL1 AARS1 NCALD GARS1 SCRN1 PGK1 PPM1H RYR2 HPCA NELL1 HSPA12A RAB4B NRXN1 DDHD2 DYNC1H1 EHBP1 COPS3 XPO7 | 5.00e-05 | 547 | 293 | 18 | M2110 |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | EPHX2 EPRS1 MYH1 AARS1 RYR1 ITPR3 XPO5 CTNNBIP1 MKI67 MGA RAB4A COL11A1 KRT34 KRT82 NPEPL1 POLR3A IFFO2 GSDMA KRT36 EPAS1 | 5.92e-05 | 659 | 293 | 20 | MM1040 |
| Coexpression | ZAMORA_NOS2_TARGETS_DN | 6.40e-05 | 89 | 293 | 7 | MM690 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 6.47e-05 | 192 | 293 | 10 | M2776 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | CDC42EP4 CYP2D6 MYO1D CYP11A1 GAS2 AKR1C4 AKR1C1 AKR1C2 RYR1 PLS3 ZNF821 NPEPL1 SLC12A2 PRAMEF14 AKR1C3 CYB561 | 7.42e-05 | 463 | 293 | 16 | MM1011 |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | SCRN1 PTGS1 PHKA2 PTBP3 SPG11 CHD7 THADA MAP4K5 ZFHX3 L3MBTL3 | 7.69e-05 | 196 | 293 | 10 | M9243 |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | MYH11 HELB MKI67 KIF11 IPO5 EI24 RFC5 ECT2 ARCN1 SLC12A2 SMC3 | 7.96e-05 | 237 | 293 | 11 | M15606 |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN | 8.36e-05 | 198 | 293 | 10 | M3792 | |
| Coexpression | IBRAHIM_NRF1_UP | TFG GTF3C3 FAF2 TMTC3 LIPH ANP32E FGFR1 PLS3 ARCN1 IWS1 SART1 MAP4K5 DDHD1 AKR1C3 CCT8 | 8.65e-05 | 420 | 293 | 15 | M42509 |
| Coexpression | GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP | 8.72e-05 | 199 | 293 | 10 | M5978 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 8.72e-05 | 199 | 293 | 10 | M5893 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN | 8.72e-05 | 199 | 293 | 10 | M6632 | |
| Coexpression | GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP | MYH4 PPM1H BEND6 RAB4A PARP12 DDHD1 AKR1C3 ZFHX3 RAB37 EPAS1 | 8.72e-05 | 199 | 293 | 10 | M5615 |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | MYH11 HELB MKI67 KIF11 IPO5 EI24 RFC5 ECT2 ARCN1 SLC12A2 SMC3 | 8.90e-05 | 240 | 293 | 11 | MM976 |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 8.90e-05 | 126 | 293 | 8 | M39132 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN | 9.09e-05 | 200 | 293 | 10 | M4587 | |
| Coexpression | GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP | 9.09e-05 | 200 | 293 | 10 | M9767 | |
| Coexpression | GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN | EPRS1 MAN2A1 PSMA2 SRP54 WASHC2A KIF24 PGK1 RBM45 ECT2 APPL1 | 9.09e-05 | 200 | 293 | 10 | M7907 |
| Coexpression | GSE360_DC_VS_MAC_UP | 9.09e-05 | 200 | 293 | 10 | M5172 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | SRP54 MCM10 MELK ITPR3 NCAPD2 MKI67 ANP32E KIF11 MAP3K8 LNPEP | 9.09e-05 | 200 | 293 | 10 | M3188 |
| Coexpression | GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN | 9.09e-05 | 200 | 293 | 10 | M6989 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL | RDH8 BNC2 MYH11 OBSCN PHKA1 CACTIN ADHFE1 INTS2 DNAH5 TNFSF15 MPP7 COL5A1 GSDMA SNTA1 | 9.33e-05 | 375 | 293 | 14 | M39162 |
| Coexpression | FISCHER_DREAM_TARGETS | AARS1 CDC42EP4 GARS1 CKAP5 NCAPH2 MCM10 NEDD1 MELK KIF24 ZNF518A NCAPD2 MKI67 ANP32E GNL3 KIF11 EHBP1 RANGAP1 NTAQ1 STIL RFC5 ECT2 TBC1D31 SMC3 CEP83 CEP295 | 1.00e-04 | 969 | 293 | 25 | M149 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | AARS1 CKAP5 NCAPH2 MCM10 MELK NCAPD2 MKI67 ANP32E KIF11 RC3H2 RANGAP1 STIL RFC5 ECT2 RAD50 TBC1D31 IFFO2 ARHGAP18 | 1.00e-04 | 578 | 293 | 18 | M2368 |
| Coexpression | GRADE_COLON_AND_RECTAL_CANCER_UP | EPRS1 AARS1 PSMA2 GARS1 MELK RAB4B PXDN USP7 PTCD3 RFC5 SLC12A2 CCT8 | 1.14e-04 | 290 | 293 | 12 | M16740 |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 1.36e-04 | 210 | 293 | 10 | MM751 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | EPRS1 MYH1 AARS1 RYR1 ITPR3 XPO5 CTNNBIP1 NCAPD2 MKI67 MGA RAB4A COL11A1 KRT34 KRT82 NPEPL1 POLR3A IFFO2 GSDMA KRT36 | 1.47e-04 | 650 | 293 | 19 | MM1042 |
| Coexpression | MAINA_VHL_TARGETS_UP | 1.57e-04 | 10 | 293 | 3 | M12942 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 1.61e-04 | 25 | 293 | 4 | MM480 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 1.79e-04 | 177 | 293 | 9 | M9401 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 1.82e-04 | 74 | 293 | 6 | MM769 | |
| Coexpression | LEE_AGING_NEOCORTEX_UP | 2.26e-04 | 77 | 293 | 6 | M1590 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | EPHX2 USP34 MYH1 AKR1C4 HMGCS2 WASHC2A AKR1C1 AKR1C2 RYR1 NCAPD2 MKI67 MGA KIF11 PTBP3 WASHC2C ARCN1 POLR3A GET3 AKR1C3 KRT36 | 2.81e-04 | 741 | 293 | 20 | MM1037 |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_UP | 2.96e-04 | 150 | 293 | 8 | MM936 | |
| Coexpression | HARRIS_HYPOXIA | 2.98e-04 | 81 | 293 | 6 | M10508 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP | 3.04e-04 | 190 | 293 | 9 | M18436 | |
| Coexpression | FAN_EMBRYONIC_CTX_NSC_2 | CKAP5 MELK NCAPD2 MKI67 ANP32E KIF11 RANGAP1 CNTRL STIL ECT2 | 3.14e-04 | 233 | 293 | 10 | M39036 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 3.33e-04 | 30 | 293 | 4 | MM853 | |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | CDC42EP4 CKAP5 MELK ZNF518A CEP350 MKI67 ANP32E KIF11 STIL ECT2 | 3.47e-04 | 236 | 293 | 10 | M130 |
| Coexpression | ABBUD_LIF_SIGNALING_2_UP | 3.64e-04 | 13 | 293 | 3 | M1439 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 3.69e-04 | 155 | 293 | 8 | M39246 | |
| Coexpression | SASSON_RESPONSE_TO_GONADOTROPHINS_UP | 4.12e-04 | 86 | 293 | 6 | M16587 | |
| Coexpression | GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP | 4.26e-04 | 199 | 293 | 9 | M3393 | |
| Coexpression | GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 4.26e-04 | 199 | 293 | 9 | M8622 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP | 4.26e-04 | 199 | 293 | 9 | M5233 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_TH1_DN | 4.26e-04 | 199 | 293 | 9 | M5533 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | CKAP5 NCAPH2 MCM10 MELK NCAPD2 MKI67 ANP32E KIF11 RC3H2 RANGAP1 STIL RFC5 ECT2 RAD50 TBC1D31 IFFO2 ARHGAP18 | 4.40e-04 | 597 | 293 | 17 | MM1309 |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP | 4.42e-04 | 200 | 293 | 9 | M4617 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP | 4.42e-04 | 200 | 293 | 9 | M9391 | |
| Coexpression | GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN | 4.42e-04 | 200 | 293 | 9 | M8069 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP | 4.42e-04 | 200 | 293 | 9 | M4599 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 4.42e-04 | 200 | 293 | 9 | M4538 | |
| Coexpression | GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP | 4.42e-04 | 200 | 293 | 9 | M7091 | |
| Coexpression | GSE28237_EARLY_VS_LATE_GC_BCELL_UP | 4.42e-04 | 200 | 293 | 9 | M4893 | |
| Coexpression | GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN | 4.42e-04 | 200 | 293 | 9 | M3491 | |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN | 4.42e-04 | 200 | 293 | 9 | M7502 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_UP | 4.42e-04 | 200 | 293 | 9 | M3822 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP | 4.42e-04 | 200 | 293 | 9 | M7713 | |
| Coexpression | GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN | 4.42e-04 | 200 | 293 | 9 | M7686 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN | 4.42e-04 | 200 | 293 | 9 | M9037 | |
| Coexpression | HAN_SATB1_TARGETS_DN | DST PXN KCNN4 GCN1 TNFSF15 NPAS2 KAT6A MYO18A LAMB3 RFC5 NSUN7 AKR1C3 XPO7 | 4.66e-04 | 388 | 293 | 13 | M15491 |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_DN | 4.76e-04 | 161 | 293 | 8 | M15047 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | USP34 DIS3L MCM10 NEDD1 CEP128 KIF24 MRTFB DST PXDN TMTC3 DDX50 CTNNBIP1 MKI67 PLS3 CHD7 STIL ECT2 TBC1D31 DDHD1 SAMD13 APPL1 CEP295 | 4.83e-04 | 892 | 293 | 22 | M18120 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D | AKR1C4 GDF10 AKR1C1 AKR1C2 ITPR2 PHKA1 PHKA2 PHKG1 PXDN KIF26B AKR1C3 | 4.96e-04 | 293 | 293 | 11 | MM895 |
| Coexpression | PAL_PRMT5_TARGETS_UP | 5.10e-04 | 204 | 293 | 9 | M10688 | |
| Coexpression | MANALO_HYPOXIA_UP | 5.28e-04 | 205 | 293 | 9 | M259 | |
| Coexpression | AMIT_EGF_RESPONSE_480_HELA | 5.38e-04 | 164 | 293 | 8 | M8729 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 5.38e-04 | 164 | 293 | 8 | M13108 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 5.45e-04 | 250 | 293 | 10 | M11318 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 ABCA13 OBSCN ADGRV1 FREM1 RYR2 FREM2 NRXN1 KIF5A DNAH5 COL11A1 DNAH10 KIF26B DNAH1 ANO3 | 2.03e-12 | 184 | 297 | 15 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 ABCA13 OBSCN ADGRV1 FREM1 RYR2 FREM2 NRXN1 KIF5A DNAH5 COL11A1 DNAH10 KIF26B DNAH1 ANO3 | 2.03e-12 | 184 | 297 | 15 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYH1 ABCA13 OBSCN ADGRV1 FREM1 RYR2 FREM2 NRXN1 KIF5A DNAH5 COL11A1 DNAH10 KIF26B DNAH1 ANO3 | 2.03e-12 | 184 | 297 | 15 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | SCRN1 TFG CEP350 PARP9 PTBP3 CNTRL IWS1 RAD50 SMC3 MAP4K5 AKR1C3 CCT8 APPL1 | 9.03e-10 | 198 | 297 | 13 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CKAP5 MCM10 MELK KIF24 PTGS1 NCAPD2 MKI67 ANP32E KIF11 RANGAP1 CNTRL STIL ECT2 | 1.02e-09 | 200 | 297 | 13 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HMGCS2 CEP128 HSPA12A NCAPD2 MKI67 C4A KIF5A KIF11 STIL ECT2 CEP295 CYB561 | 3.85e-09 | 182 | 297 | 12 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CKAP5 MCM10 MELK KIF24 NCAPD2 MKI67 ANP32E KIF11 RANGAP1 CNTRL STIL ECT2 | 1.05e-08 | 199 | 297 | 12 | 98575fcce726589e93fbb4df1aab03e57cb56076 |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | CKAP5 MCM10 CEP128 MELK KIF24 NCAPD2 MKI67 ANP32E KIF11 CNTRL STIL ECT2 | 1.11e-08 | 200 | 297 | 12 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CEACAM8 SERPINB11 A2ML1 DNAH5 DNAH3 DNAH10 SYT6 DNAH2 DNAH7 NSUN7 DNAH1 AKR1C3 | 1.11e-08 | 200 | 297 | 12 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CEACAM8 SERPINB11 A2ML1 DNAH5 DNAH3 DNAH10 SYT6 DNAH2 DNAH7 NSUN7 DNAH1 AKR1C3 | 1.11e-08 | 200 | 297 | 12 | da12821e8a0657869ca0f75d351cce2d7605a505 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | CKAP5 MCM10 CEP128 MELK KIF24 NCAPD2 MKI67 KIF11 RANGAP1 STIL ECT2 | 5.02e-08 | 185 | 297 | 11 | 30e041d6f6e310d64809e9d6d93cd30052972f3b |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | ADGRV1 MELK FREM2 MKI67 MPP7 KIF11 COL11A1 SH3GL2 STIL ECT2 NSUN7 | 6.95e-08 | 191 | 297 | 11 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | CKAP5 CEP128 MELK KIF24 NCAPD2 MKI67 KIF11 RANGAP1 STIL ECT2 TBC1D31 | 7.33e-08 | 192 | 297 | 11 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ADGRV1 PPM1H CFAP299 FREM2 MPP7 COL11A1 SH3GL2 LAMB3 ECT2 NSUN7 LRRC36 | 7.33e-08 | 192 | 297 | 11 | 25378b5e4b0cea8415ff125783511fc25a56fc00 |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | CHL1 ABCA13 ADGRV1 CFAP299 MRTFB DNAH5 DNAH3 FAM184A DNAH10 DNAH2 DNAH7 | 7.72e-08 | 193 | 297 | 11 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | USP34 EPRS1 MAN2A1 CKAP5 ADGRV1 GTF3C3 CEP350 MGA DYNC1H1 CLOCK APPL1 | 7.72e-08 | 193 | 297 | 11 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | CKAP5 MELK NCAPD2 MKI67 ANP32E KIF11 RANGAP1 STIL ECT2 CEP295 EPAS1 | 9.51e-08 | 197 | 297 | 11 | 1c89d6836eed30c50c765f7dde9cc8ee15c363d2 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | SCRN1 CEP350 TMTC3 PARP9 DNAH5 PTBP3 CNTRL IWS1 RAD50 SMC3 MAP4K5 | 1.05e-07 | 199 | 297 | 11 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CEACAM8 AKR1C1 SERPINB11 A2ML1 DNAH5 DNAH10 SYT6 DNAH2 DNAH7 DNAH1 AKR1C3 | 1.05e-07 | 199 | 297 | 11 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CEACAM8 AKR1C1 SERPINB11 A2ML1 DNAH5 DNAH10 SYT6 DNAH2 DNAH7 DNAH1 AKR1C3 | 1.05e-07 | 199 | 297 | 11 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue|TCGA-Stomach / Sample_Type by Project: Shred V9 | DAB1 AKR1C1 PTGS1 AKR1C2 ADHFE1 NRXN1 ANKRD35 AMPD1 SH3GL2 CBR1 | 2.39e-07 | 171 | 297 | 10 | 0f8d038858a4618b4348becc26a618d43b10d9d6 |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal|TCGA-Stomach / Sample_Type by Project: Shred V9 | DAB1 AKR1C1 PTGS1 AKR1C2 ADHFE1 NRXN1 ANKRD35 AMPD1 SH3GL2 CBR1 | 2.39e-07 | 171 | 297 | 10 | 791d37fe94ff2820fb409bbd38b31799df700ba1 |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue|TCGA-Stomach / Sample_Type by Project: Shred V9 | DAB1 AKR1C1 PTGS1 AKR1C2 ADHFE1 NRXN1 ANKRD35 AMPD1 SH3GL2 CBR1 | 2.39e-07 | 171 | 297 | 10 | 0bf36930bd7fc63691f48a15db93deb1dd937c10 |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 2.66e-07 | 173 | 297 | 10 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | BNC2 CKAP5 GDF10 CEP128 MELK ADHFE1 MKI67 COL5A1 COL11A1 TBC1D31 | 2.81e-07 | 174 | 297 | 10 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-07 | 176 | 297 | 10 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-07 | 176 | 297 | 10 | 8385435074cc5235b7af7424974f609388fc2cff | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | CKAP5 CEP128 MELK NCAPD2 MKI67 ANP32E KIF11 RANGAP1 STIL ECT2 | 3.84e-07 | 180 | 297 | 10 | 5e1680088065be14447d5d5465f91f7edd071a1e |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CKAP5 CEP128 MELK KIF24 NCAPD2 MKI67 KIF11 STIL ECT2 TBC1D31 | 3.84e-07 | 180 | 297 | 10 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.47e-07 | 183 | 297 | 10 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.89e-07 | 142 | 297 | 9 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.19e-07 | 186 | 297 | 10 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.45e-07 | 187 | 297 | 10 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.45e-07 | 187 | 297 | 10 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.45e-07 | 187 | 297 | 10 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.45e-07 | 187 | 297 | 10 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 5.73e-07 | 188 | 297 | 10 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CKAP5 CEP128 MELK KIF24 NCAPD2 MKI67 ANP32E KIF11 ECT2 TBC1D31 | 6.01e-07 | 189 | 297 | 10 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.01e-07 | 189 | 297 | 10 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ADGRV1 CFAP299 FREM2 DNAH5 TBX1 MPP7 SH3GL2 LAMB3 DNAH7 NSUN7 | 6.62e-07 | 191 | 297 | 10 | 60ff989fe99d243a3d52955223680cdd1f1917a4 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | CKAP5 CEP128 MELK NCAPD2 MKI67 KIF11 RANGAP1 STIL ECT2 TBC1D31 | 6.62e-07 | 191 | 297 | 10 | 0ba5b112a82e489f5a21966f78a403a7436ce73b |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 6.62e-07 | 191 | 297 | 10 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | CKAP5 MELK KIF24 NCAPD2 MKI67 KIF11 RANGAP1 STIL ECT2 TBC1D31 | 6.94e-07 | 192 | 297 | 10 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-07 | 192 | 297 | 10 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ADGRV1 DNAH14 ITPR3 FREM2 HPCAL1 TNFSF15 MPP7 FAM184A COL11A1 LRRC36 | 6.94e-07 | 192 | 297 | 10 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-07 | 192 | 297 | 10 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | CKAP5 CEP128 MELK NCAPD2 MKI67 KIF11 STIL ECT2 TBC1D31 CEP295 | 7.28e-07 | 193 | 297 | 10 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.63e-07 | 194 | 297 | 10 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | ADGRV1 CFAP299 FREM2 DNAH5 TBX1 MPP7 SH3GL2 LAMB3 DNAH7 NSUN7 | 7.63e-07 | 194 | 297 | 10 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CKAP5 MELK NCAPD2 MKI67 ANP32E KIF11 RANGAP1 CNTRL STIL ECT2 | 8.00e-07 | 195 | 297 | 10 | 742c82c86487314cdb3178012004adb1164bcbdb |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 8.00e-07 | 195 | 297 | 10 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | CKAP5 MELK NCAPD2 MKI67 ANP32E KIF11 RANGAP1 STIL ECT2 EPAS1 | 8.38e-07 | 196 | 297 | 10 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | CKAP5 MELK NCAPD2 MKI67 ANP32E KIF11 RANGAP1 STIL ECT2 EPAS1 | 8.38e-07 | 196 | 297 | 10 | 20383d576708b7e4bfce3e9fe40548cce496e3cb |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.38e-07 | 196 | 297 | 10 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | SERPINB11 DNAH5 DNAH3 DNAH10 SYT6 DNAH2 DNAH7 NSUN7 DNAH1 ANO3 | 9.19e-07 | 198 | 297 | 10 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | CKAP5 MELK NCAPD2 MKI67 ANP32E KIF11 RANGAP1 CNTRL ECT2 TBC1D31 | 9.19e-07 | 198 | 297 | 10 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | SERPINB11 DNAH5 DNAH3 DNAH10 SYT6 DNAH2 DNAH7 NSUN7 DNAH1 ANO3 | 9.19e-07 | 198 | 297 | 10 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 |
| ToppCell | (5)_Dendritic_cell-(52)_cycling_DCs|(5)_Dendritic_cell / shred on Cell_type and subtype | 9.62e-07 | 199 | 297 | 10 | d0ff446a197062b10f37b585f3f8716d6d89e5b7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.62e-07 | 199 | 297 | 10 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | SRP54 SCRN1 TFG CEP350 PARP9 CNTRL RAD50 SMC3 MAP4K5 ARHGAP18 | 9.62e-07 | 199 | 297 | 10 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.62e-07 | 199 | 297 | 10 | 47466253069d4b1b8f13ce3210f434e60753b38a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | CKAP5 MCM10 MELK NCAPD2 MKI67 ANP32E KIF11 RANGAP1 STIL ECT2 | 9.62e-07 | 199 | 297 | 10 | d8f904f531bfe091b7d8caaa147ea4a03d627995 |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate|GW08 / Sample Type, Dataset, Time_group, and Cell type. | EPHX2 CYP11A1 FAM186B KIF24 ZNF829 HSPA12A KCNN4 RC3H2 CHAMP1 DDHD1 | 1.01e-06 | 200 | 297 | 10 | 401d50fa394fa863fa7836344110ae5c7af3250a |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | AKR1C1 SERPINB11 A2ML1 DNAH5 DNAH3 DNAH10 SYT6 DNAH2 DNAH7 AKR1C3 | 1.01e-06 | 200 | 297 | 10 | cf191104484bfb2b9f87de416b9453135f8833c1 |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NCALD ADGRV1 PPM1H MRTFB LIPH KCNN4 MCF2L MPP7 NPAS2 SLC12A2 | 1.01e-06 | 200 | 297 | 10 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | AKR1C1 SERPINB11 A2ML1 DNAH5 DNAH3 DNAH10 SYT6 DNAH2 DNAH7 AKR1C3 | 1.01e-06 | 200 | 297 | 10 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | SCRN1 ADGRV1 MCM10 MELK MKI67 ANP32E KIF11 COL11A1 CHD7 SMC3 | 1.01e-06 | 200 | 297 | 10 | dc1c1506823eaa105f1532c6b5d4efa14e788314 |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | MYT1L CHL1 NCALD DAB1 NELL1 PXDN COL11A1 DSCAM KIF26B PCDH11Y | 1.01e-06 | 200 | 297 | 10 | 961858738ce35db8760c8c2e136f8369bc444ccf |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | MYT1L CHL1 NCALD DAB1 NELL1 PXDN COL11A1 DSCAM KIF26B PCDH11Y | 1.01e-06 | 200 | 297 | 10 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | MYT1L CHL1 NCALD DAB1 NELL1 PXDN COL11A1 DSCAM KIF26B PCDH11Y | 1.01e-06 | 200 | 297 | 10 | cc3409518f8b436ea92deb955e81114b3f410ff7 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | MYT1L CHL1 NCALD DAB1 NELL1 PXDN COL11A1 DSCAM KIF26B PCDH11Y | 1.01e-06 | 200 | 297 | 10 | c24a3099e3d96d8b72f6d05286bb355d661a0377 |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | SCRN1 ADGRV1 MCM10 MELK MKI67 ANP32E KIF11 COL11A1 CHD7 SMC3 | 1.01e-06 | 200 | 297 | 10 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | MYT1L CHL1 NCALD DAB1 NELL1 PXDN COL11A1 DSCAM KIF26B PCDH11Y | 1.01e-06 | 200 | 297 | 10 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | MYT1L CHL1 NCALD DAB1 NELL1 PXDN COL11A1 DSCAM KIF26B PCDH11Y | 1.01e-06 | 200 | 297 | 10 | 310cd53db1c137f6af74e6ae682221d7ac27310c |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-06 | 163 | 297 | 9 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-06 | 164 | 297 | 9 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 165 | 297 | 9 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-06 | 169 | 297 | 9 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-06 | 169 | 297 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-06 | 172 | 297 | 9 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 2.54e-06 | 173 | 297 | 9 | d815832f89f70662706620e3b03ebb1dabec0034 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 2.54e-06 | 173 | 297 | 9 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-06 | 174 | 297 | 9 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-06 | 174 | 297 | 9 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.79e-06 | 175 | 297 | 9 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.79e-06 | 175 | 297 | 9 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.98e-06 | 132 | 297 | 8 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-06 | 177 | 297 | 9 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-06 | 177 | 297 | 9 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-06 | 177 | 297 | 9 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-06 | 179 | 297 | 9 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-06 | 180 | 297 | 9 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 182 | 297 | 9 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 182 | 297 | 9 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.02e-06 | 183 | 297 | 9 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-06 | 184 | 297 | 9 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.39e-06 | 185 | 297 | 9 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.39e-06 | 185 | 297 | 9 | d9039770226338fbc3fce92aa229fad96e16db8c | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.39e-06 | 185 | 297 | 9 | b931ab35da10e6e3877071dce9b13fc0da63dc88 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-06 | 186 | 297 | 9 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| Drug | cloxazolam | 2.80e-08 | 4 | 296 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 2.80e-08 | 4 | 296 | 4 | ctd:D011278 | |
| Drug | tetralol | 2.80e-08 | 4 | 296 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 2.80e-08 | 4 | 296 | 4 | ctd:C018156 | |
| Drug | oxcarbazepine | 1.08e-07 | 19 | 296 | 6 | ctd:C036006 | |
| Drug | Hydroxysteroids | 1.39e-07 | 5 | 296 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 1.39e-07 | 5 | 296 | 4 | ctd:C010092 | |
| Drug | Dihydroxydihydrobenzopyrenes | 1.56e-07 | 11 | 296 | 5 | ctd:D004101 | |
| Drug | Medazepam | 4.11e-07 | 6 | 296 | 4 | ctd:D008472 | |
| Drug | DMBA-3,4-dihydrodiol | 4.24e-07 | 13 | 296 | 5 | CID000050096 | |
| Drug | flunisolide | 4.24e-07 | 13 | 296 | 5 | ctd:C007734 | |
| Drug | AC1L1IZ2 | MYH1 MYH4 MYH11 MYO1D GARS1 PGK1 PGK2 RYR1 RYR2 PHKA2 CTNNBIP1 PLS3 DYNC1H1 KIF11 MYO18A PANX2 RFC5 | 5.55e-07 | 304 | 296 | 17 | CID000004795 |
| Drug | AC1NRAG8 | 6.53e-07 | 14 | 296 | 5 | CID005287861 | |
| Drug | polybrene | 7.06e-07 | 57 | 296 | 8 | CID000024769 | |
| Drug | 20 alpha-dihydroprogesterone | 7.55e-07 | 40 | 296 | 7 | CID000008956 | |
| Drug | Biliton | 9.00e-07 | 41 | 296 | 7 | CID000002974 | |
| Drug | AC1L1IZE | AARS1 GARS1 RYR1 RYR2 PHKA2 DNAH5 DNAH8 DYNC1H1 DNAH3 DNAH10 DNAH1 | 1.19e-06 | 131 | 296 | 11 | CID000004799 |
| Drug | naphthalene-1,2-dihydrodiol | 1.74e-06 | 45 | 296 | 7 | CID000000362 | |
| Drug | Nitrazepam | 1.88e-06 | 8 | 296 | 4 | ctd:D009567 | |
| Drug | cyclopentanol | 2.18e-06 | 3 | 296 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 2.18e-06 | 3 | 296 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 2.18e-06 | 3 | 296 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 2.18e-06 | 3 | 296 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 2.18e-06 | 3 | 296 | 3 | ctd:C530610 | |
| Drug | NSC641520 | 3.12e-06 | 69 | 296 | 8 | CID000003593 | |
| Drug | 4-hydroxybenzoic acid | 3.35e-06 | 9 | 296 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 3.35e-06 | 9 | 296 | 4 | ctd:D004092 | |
| Drug | Chrysenes | 4.74e-06 | 20 | 296 | 5 | ctd:D002911 | |
| Drug | octyl gallate | 5.53e-06 | 10 | 296 | 4 | ctd:C016627 | |
| Drug | Flunitrazepam | 6.16e-06 | 21 | 296 | 5 | ctd:D005445 | |
| Drug | benzene dihydrodiol | 7.89e-06 | 22 | 296 | 5 | CID000000418 | |
| Drug | chlordecone alcohol | 8.60e-06 | 11 | 296 | 4 | CID000013946 | |
| Drug | tetrahydrodeoxycorticosterone | 8.62e-06 | 4 | 296 | 3 | ctd:C009413 | |
| Drug | gliquidone | 8.62e-06 | 4 | 296 | 3 | ctd:C010969 | |
| Drug | DBD-H | 8.62e-06 | 4 | 296 | 3 | CID000131382 | |
| Drug | Ascorbic Acid | EPHX2 EPRS1 AARS1 MYH11 NCALD CYP11A1 GARS1 DAB2 GDF10 PTGS1 AKR1C2 FABP6 NRXN1 NFKB1 GLS MKI67 TAGLN PLS3 SDHA COL11A1 RAD50 TLR4 EPAS1 | 8.97e-06 | 628 | 296 | 23 | ctd:D001205 |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A | EPHX2 NCAPH2 CACTIN ERAP2 PXN NMT1 RC3H2 ARHGAP35 NPEPL1 ZFHX3 CYB561 XPO7 | 9.56e-06 | 194 | 296 | 12 | 4612_DN |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; HL60; HT_HG-U133A | NCALD CDC42EP4 ZZEF1 DDX6 ITPR2 CACTIN GLS ATL2 ZNF821 RANBP3 NPEPL1 LNPEP | 1.17e-05 | 198 | 296 | 12 | 2140_DN |
| Drug | Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; HL60; HT_HG-U133A | AKR1C4 MEP1B DNAJC28 GMPR LRRN2 KIF5A MCF2L PLS3 SUPT3H COL11A1 FSD1 ARHGAP35 | 1.17e-05 | 198 | 296 | 12 | 2518_UP |
| Drug | Glycyrrhetinic Acid | 1.25e-05 | 24 | 296 | 5 | ctd:D006034 | |
| Drug | Phenolphthalein | 1.28e-05 | 12 | 296 | 4 | ctd:D020113 | |
| Drug | 9,10-phenanthrenequinone | 1.54e-05 | 25 | 296 | 5 | ctd:C005399 | |
| Drug | glycolithocholic acid | 1.89e-05 | 26 | 296 | 5 | CID000115245 | |
| Drug | NSC86000 | 2.13e-05 | 5 | 296 | 3 | CID000257630 | |
| Drug | 4-hydroxyochratoxin A | 2.13e-05 | 5 | 296 | 3 | CID000114713 | |
| Drug | B0683 | 2.28e-05 | 117 | 296 | 9 | CID006398969 | |
| Drug | dienogest | 2.29e-05 | 27 | 296 | 5 | ctd:C023635 | |
| Drug | 5-alpha-Dihydroprogesterone | 2.53e-05 | 14 | 296 | 4 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 2.53e-05 | 14 | 296 | 4 | CID000022750 | |
| Drug | Meclofenamic Acid | 2.53e-05 | 14 | 296 | 4 | ctd:D008469 | |
| Drug | Methylcholanthrene | EPHX2 MYO1D DAB2 MCM10 MELK AKR1C1 PTGS1 FABP6 MEP1B PHKA2 FREM2 MRTFB MKI67 TRIM55 KCNN4 C4A C4B FGFR1 KIF11 COL5A1 AMPD1 COL11A1 ANK2 ARHGAP35 RFC5 ECT2 CBR1 EEF1B2 CCT8 EPAS1 | 3.65e-05 | 1034 | 296 | 30 | ctd:D008748 |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | CAPN9 USP34 NCAPH2 RYR2 MEP1B USP7 RANGAP1 FAM184A MAP3K8 CNTRL LAMB3 | 4.13e-05 | 190 | 296 | 11 | 6979_UP |
| Drug | AC1L93E5 | 4.23e-05 | 6 | 296 | 3 | CID000412383 | |
| Drug | Estazolam | 4.23e-05 | 6 | 296 | 3 | ctd:D004949 | |
| Drug | 10-hydroxyochratoxin A | 4.23e-05 | 6 | 296 | 3 | CID000135115 | |
| Drug | 3-hydroxyhexobarbital | 4.23e-05 | 6 | 296 | 3 | CID000439898 | |
| Drug | Glipizide | 4.23e-05 | 6 | 296 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 4.23e-05 | 6 | 296 | 3 | ctd:C023723 | |
| Drug | Bay e 4609 | 4.50e-05 | 16 | 296 | 4 | CID003085308 | |
| Drug | butylethanolamine | 4.50e-05 | 16 | 296 | 4 | CID000249006 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 4.62e-05 | 31 | 296 | 5 | ctd:C017228 | |
| Drug | formycin triphosphate | 5.06e-05 | 51 | 296 | 6 | CID000122274 | |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; MCF7; HT_HG-U133A | CAPN9 PTGS1 DDX6 FER GMPR FGFR1 MAP3K8 RANBP3 ARHGAP35 CGREF1 MAP4K5 | 5.24e-05 | 195 | 296 | 11 | 3286_DN |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; PC3; HT_HG-U133A | TRAF1 CYP3A5 GAS2 PGK2 F13A1 ITPR2 MCF2L AIM2 TNFSF15 KIF26B RAD50 | 5.48e-05 | 196 | 296 | 11 | 3690_UP |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; HL60; HT_HG-U133A | RDH8 TRIO ITPR2 TNFSF15 PARP12 COL5A1 COL11A1 ANK2 ARHGAP35 NPEPL1 ZFHX3 | 5.74e-05 | 197 | 296 | 11 | 3048_UP |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; MCF7; HT_HG-U133A | EPHX2 PTGS1 CACTIN DNAJC28 CTNNBIP1 FGFR1 IPO5 COL5A1 DNAH3 ARHGAP35 ZFHX3 | 5.74e-05 | 197 | 296 | 11 | 5410_DN |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; PC3; HT_HG-U133A | CHL1 CYP3A5 LRCH1 PXN TNFSF15 COL5A1 ZNF821 FAM184A HSF2BP ARHGAP35 MAP4K5 | 6.01e-05 | 198 | 296 | 11 | 5829_UP |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 7.32e-05 | 7 | 296 | 3 | CID009547999 | |
| Drug | SC-11927 | 7.32e-05 | 7 | 296 | 3 | CID003034422 | |
| Drug | 4-hydroxyequilenin-o-quinone | 7.32e-05 | 7 | 296 | 3 | ctd:C117714 | |
| Drug | zomepirac | 7.32e-05 | 7 | 296 | 3 | ctd:C020549 | |
| Drug | Br2BAPTA | 7.32e-05 | 7 | 296 | 3 | CID003081001 | |
| Drug | Thapsigargin | EPRS1 BNC2 AARS1 NCALD PSMA2 GARS1 CKAP5 MCM10 MELK KIF24 PGK1 HELB ITPR3 HPCA ADHFE1 BEND6 XPO5 GLS MKI67 KCNN4 TAF1L PLS3 SDHA KIF11 IPO5 COL5A1 COL11A1 SPG11 RFC5 NPEPL1 ARCN1 POLR3A RAD50 SMC3 EPAS1 | 8.36e-05 | 1353 | 296 | 35 | ctd:D019284 |
| Drug | flufenamic acid | 8.49e-05 | 108 | 296 | 8 | CID000003371 | |
| Drug | ketorolac | 9.30e-05 | 19 | 296 | 4 | CID000003826 | |
| Drug | 1,2-dihydroxynaphthalene | 9.54e-05 | 57 | 296 | 6 | CID000011318 | |
| Drug | NSC36919 | 1.05e-04 | 58 | 296 | 6 | CID000235496 | |
| Drug | purealin | 1.05e-04 | 58 | 296 | 6 | CID006419303 | |
| Drug | benzo(a)pyrene-7,8-dione | 1.15e-04 | 20 | 296 | 4 | ctd:C076588 | |
| Drug | 2-cyclohexen-1-ol | 1.16e-04 | 8 | 296 | 3 | CID000013198 | |
| Drug | hydroxynortriptyline | 1.16e-04 | 8 | 296 | 3 | CID005352542 | |
| Drug | lactate | ADGRV1 PGK1 PGK2 RYR1 PHKA2 PHKB ADHFE1 DST GLS TNFSF15 AMPD1 TWNK WBP2NL DNAH7 EEF1B2 MAP4K5 APPL1 | 1.24e-04 | 461 | 296 | 17 | CID000000612 |
| Drug | 21-deoxycortisol | 1.44e-04 | 39 | 296 | 5 | CID000092827 | |
| Drug | 5 alpha-androstane-3 beta,17 beta-diol | CYP3A5 CYP11A1 AKR1C4 AKR1C1 PTGS1 AKR1C2 ADHFE1 C4A COL11A1 AKR1C3 | 1.62e-04 | 185 | 296 | 10 | CID000011301 |
| Drug | Methamphetamine | NCALD CYP2D6 DIS3L CYP11A1 PSMA2 OBSCN SYT9 MCM10 ZZEF1 PTGS1 PGK1 ITPR2 HPCA PHKG1 DST TMTC3 NFKB1 GLS MKI67 PXN KPNA4 AMPD1 WASHC2C RANBP3 SH3GL2 KAT6A MYO18A HSF2BP ECT2 CBR1 DNAH1 CPTP THADA SMC3 P4HA1 | 1.64e-04 | 1401 | 296 | 35 | ctd:D008694 |
| Drug | alpha-methylcinnamic acid | 1.68e-04 | 2 | 296 | 2 | ctd:C510582 | |
| Drug | 5-nitro-1,3-benzodioxole | 1.68e-04 | 2 | 296 | 2 | CID000075798 | |
| Drug | 4-Arsono-2-hydroxybutanoic acid | 1.68e-04 | 2 | 296 | 2 | CID000135804 | |
| Drug | adenophostin A | 1.68e-04 | 2 | 296 | 2 | ctd:C085029 | |
| Drug | 2-propoxyphenol | 1.68e-04 | 2 | 296 | 2 | CID000080476 | |
| Drug | oracine | 1.68e-04 | 2 | 296 | 2 | ctd:C103439 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 1.68e-04 | 2 | 296 | 2 | DB07768 | |
| Drug | 4-chlorophenacylbromide | 1.68e-04 | 2 | 296 | 2 | CID000068303 | |
| Drug | baccharin | 1.68e-04 | 2 | 296 | 2 | ctd:C012764 | |
| Drug | AC1MI08J | 1.72e-04 | 9 | 296 | 3 | CID003035924 | |
| Drug | 2-bromopropionate | 1.72e-04 | 9 | 296 | 3 | CID000011729 | |
| Drug | o-quinone | 1.83e-04 | 41 | 296 | 5 | CID000011421 | |
| Drug | nocodazole | MYH1 MYH4 MYH11 MAN2A1 GARS1 GAS2 ITPR3 CEP350 RAB4A PLS3 DYNC1H1 KIF11 RANGAP1 MYO18A FSD1 ECT2 APPL1 | 1.86e-04 | 477 | 296 | 17 | CID000004122 |
| Drug | testosterone enanthate | USP34 EPRS1 MYH11 CYP11A1 DAB2 HMGCS2 AKR1C1 AKR1C2 PXDN FAF2 ERAP2 TBX1 COL5A1 ECT2 CBR1 RAD50 SMC3 AKR1C3 SERPINC1 | 2.08e-04 | 575 | 296 | 19 | ctd:C004648 |
| Drug | C75; Down 200; 10uM; PC3; HT_HG-U133A | EPHX2 NCAPH2 LRCH1 DNAJC28 FGFR1 PTBP3 DSCAM LMTK2 CGREF1 SLC24A1 | 2.10e-04 | 191 | 296 | 10 | 6399_DN |
| Disease | Neoplasms, Hormone-Dependent | 8.73e-07 | 3 | 283 | 3 | C0027661 | |
| Disease | Glycogen phosphorylase kinase deficiency | 3.47e-06 | 4 | 283 | 3 | cv:C0268147 | |
| Disease | Intersex Conditions | 8.61e-06 | 5 | 283 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 8.61e-06 | 5 | 283 | 3 | C2930619 | |
| Disease | Hermaphroditism | 8.61e-06 | 5 | 283 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 8.61e-06 | 5 | 283 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 8.61e-06 | 5 | 283 | 3 | C0033804 | |
| Disease | Malignant neoplasm of prostate | TRAF1 CYP3A5 RAB4B FAF2 USP7 MGA TAF1L EHBP1 COL5A1 PCDH11Y KAT6A EI24 LMTK2 CHD7 CBR1 SLC12A2 TLR4 AKR1C3 ZFHX3 | 9.24e-06 | 616 | 283 | 19 | C0376358 |
| Disease | Prostatic Neoplasms | TRAF1 CYP3A5 RAB4B FAF2 USP7 MGA TAF1L EHBP1 COL5A1 PCDH11Y KAT6A EI24 LMTK2 CHD7 CBR1 SLC12A2 TLR4 AKR1C3 ZFHX3 | 9.24e-06 | 616 | 283 | 19 | C0033578 |
| Disease | Disorders of Sex Development | 2.97e-05 | 7 | 283 | 3 | C0036875 | |
| Disease | Degenerative polyarthritis | 3.25e-05 | 93 | 283 | 7 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 3.25e-05 | 93 | 283 | 7 | C0086743 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 9.17e-05 | 2 | 283 | 2 | C1839840 | |
| Disease | endoplasmic reticulum aminopeptidase 2 measurement | 9.17e-05 | 2 | 283 | 2 | EFO_0801566 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 9.17e-05 | 2 | 283 | 2 | cv:C1839840 | |
| Disease | 46,XY SEX REVERSAL 8 | 9.17e-05 | 2 | 283 | 2 | 614279 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 9.17e-05 | 2 | 283 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | Glycogen Storage Disease, Type IXD | 9.17e-05 | 2 | 283 | 2 | C1845151 | |
| Disease | Marles Greenberg Persaud syndrome | 9.17e-05 | 2 | 283 | 2 | C1855425 | |
| Disease | testosterone measurement | UGT2A2 AKR1C4 AKR1C2 DDX6 NRXN1 NFKB1 USP7 FGFR1 ATP8B3 FAM184A ANK2 DSCAM NTAQ1 DNAH2 LAMB3 CHD7 SCGN CHAMP1 NPEPL1 THADA MAP4K5 AKR1C3 ZFHX3 SLC24A1 L3MBTL3 EPAS1 LRRC36 | 1.10e-04 | 1275 | 283 | 27 | EFO_0004908 |
| Disease | cardiovascular disease | USP34 RDH8 NCALD FREM1 ERAP2 MCF2L NMT1 KPNA4 HSF2BP ARHGEF18 DDX56 THADA MAP4K5 CYB561 | 1.50e-04 | 457 | 283 | 14 | EFO_0000319 |
| Disease | systemic scleroderma | 1.71e-04 | 85 | 283 | 6 | EFO_0000717 | |
| Disease | Autism Spectrum Disorders | 1.71e-04 | 85 | 283 | 6 | C1510586 | |
| Disease | C-reactive protein measurement | USP34 BNC2 PEX14 ZZEF1 DDX6 HSPA12A PXDN COMMD1 NFKB1 PXN NKPD1 HFM1 AIM2 GCN1 MAP3K8 SPG11 CHD7 NPEPL1 TLR10 RADIL ABCA6 MAP4K5 RAB37 L3MBTL3 ARMH4 | 2.73e-04 | 1206 | 283 | 25 | EFO_0004458 |
| Disease | hereditary spastic paraplegia 28 (implicated_via_orthology) | 2.73e-04 | 3 | 283 | 2 | DOID:0110779 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.73e-04 | 3 | 283 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.73e-04 | 3 | 283 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia 54 (implicated_via_orthology) | 2.73e-04 | 3 | 283 | 2 | DOID:0110806 (implicated_via_orthology) | |
| Disease | PR interval | MYH11 DAB1 OBSCN LRCH1 RYR2 NELL1 FREM2 FER HFM1 FGFR1 SUPT3H MICU2 EPAS1 XPO7 | 3.38e-04 | 495 | 283 | 14 | EFO_0004462 |
| Disease | Ovarian Cysts | 3.43e-04 | 35 | 283 | 4 | C0029927 | |
| Disease | Corpus Luteum Cyst | 3.43e-04 | 35 | 283 | 4 | C0010093 | |
| Disease | urate measurement, bone density | PEX14 DNAH14 FREM1 ITPR2 FSIP2 NELL1 HPCAL1 A2ML1 DNAH8 MPPED1 MPP7 COL5A1 DSCAM DNAH1 MAP4K5 CEP83 | 3.53e-04 | 619 | 283 | 16 | EFO_0003923, EFO_0004531 |
| Disease | Acrocephaly | 4.46e-04 | 16 | 283 | 3 | C0030044 | |
| Disease | Trigonocephaly | 4.46e-04 | 16 | 283 | 3 | C0265535 | |
| Disease | Scaphycephaly | 4.46e-04 | 16 | 283 | 3 | C0265534 | |
| Disease | Synostotic Anterior Plagiocephaly | 4.46e-04 | 16 | 283 | 3 | C2931150 | |
| Disease | Synostotic Posterior Plagiocephaly | 4.46e-04 | 16 | 283 | 3 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 4.46e-04 | 16 | 283 | 3 | C4551902 | |
| Disease | Metopic synostosis | 4.46e-04 | 16 | 283 | 3 | C1860819 | |
| Disease | Colorectal Carcinoma | CHL1 ABCA13 PSMA2 OBSCN SYT9 TFG NELL1 MKI67 DNAH8 TBX1 TBX22 AMPD1 DNAH3 ANK2 LAMB3 ABCA6 TLR4 | 4.88e-04 | 702 | 283 | 17 | C0009402 |
| Disease | body weight | MYT1L AARS1 NCALD DAB2 ADGRV1 ZZEF1 PGK1 DNAH14 DDX6 NELL1 NRXN1 MGA TBX22 EHBP1 PTBP3 COL11A1 CHD7 RFC5 TBC1D31 SLC12A2 MAP4K5 ZFHX3 L3MBTL3 EPAS1 XPO7 | 5.26e-04 | 1261 | 283 | 25 | EFO_0004338 |
| Disease | Glycogen storage disease | 5.37e-04 | 17 | 283 | 3 | cv:C0017919 | |
| Disease | Brachycephaly | 5.37e-04 | 17 | 283 | 3 | C0221356 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 5.37e-04 | 17 | 283 | 3 | cv:C0270914 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 5.43e-04 | 4 | 283 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 7.62e-04 | 43 | 283 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | Prescription Drug Abuse | 8.67e-04 | 115 | 283 | 6 | C4316881 | |
| Disease | Substance-Related Disorders | 8.67e-04 | 115 | 283 | 6 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 8.67e-04 | 115 | 283 | 6 | C0029231 | |
| Disease | Drug habituation | 8.67e-04 | 115 | 283 | 6 | C0013170 | |
| Disease | Drug abuse | 8.67e-04 | 115 | 283 | 6 | C0013146 | |
| Disease | Drug Use Disorders | 8.67e-04 | 115 | 283 | 6 | C0013222 | |
| Disease | Drug Dependence | 8.67e-04 | 115 | 283 | 6 | C1510472 | |
| Disease | Substance Dependence | 8.67e-04 | 115 | 283 | 6 | C0038580 | |
| Disease | Substance Use Disorders | 8.67e-04 | 115 | 283 | 6 | C0038586 | |
| Disease | Craniosynostosis | 8.82e-04 | 20 | 283 | 3 | C0010278 | |
| Disease | disseminated intravascular coagulation (is_implicated_in) | 8.99e-04 | 5 | 283 | 2 | DOID:11247 (is_implicated_in) | |
| Disease | Aneuploidy | 8.99e-04 | 5 | 283 | 2 | C0002938 | |
| Disease | response to bevacizumab, Proteinuria | 8.99e-04 | 5 | 283 | 2 | EFO_0005943, HP_0000093 | |
| Disease | spine bone mineral density change measurement, response to combination chemotherapy | 8.99e-04 | 5 | 283 | 2 | EFO_0007965, EFO_0008474 | |
| Disease | lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement | 8.99e-04 | 5 | 283 | 2 | EFO_0800429 | |
| Disease | pregnenolone sulfate measurement | 8.99e-04 | 5 | 283 | 2 | EFO_0800303 | |
| Disease | Substance abuse problem | 9.07e-04 | 116 | 283 | 6 | C0740858 | |
| Disease | Obsessive-compulsive trait | 1.02e-03 | 21 | 283 | 3 | HP_0008770 | |
| Disease | epilepsy (implicated_via_orthology) | 1.04e-03 | 163 | 283 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Cleft Palate | 1.11e-03 | 81 | 283 | 5 | C0008925 | |
| Disease | obesity (implicated_via_orthology) | 1.17e-03 | 215 | 283 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | otitis media (implicated_via_orthology) | 1.17e-03 | 22 | 283 | 3 | DOID:10754 (implicated_via_orthology) | |
| Disease | pappalysin-1 measurement | 1.34e-03 | 6 | 283 | 2 | EFO_0802845 | |
| Disease | 3-ureidopropionate measurement | 1.34e-03 | 6 | 283 | 2 | EFO_0010641 | |
| Disease | Kallmann Syndrome 2 (disorder) | 1.34e-03 | 6 | 283 | 2 | C1563720 | |
| Disease | Kallmann Syndrome 1 | 1.34e-03 | 6 | 283 | 2 | C1563719 | |
| Disease | cortolone glucuronide (1) measurement | 1.34e-03 | 6 | 283 | 2 | EFO_0800552 | |
| Disease | Hypogonadism with anosmia | 1.34e-03 | 6 | 283 | 2 | cv:C0162809 | |
| Disease | Kallmann syndrome, type 3, recessive | 1.34e-03 | 6 | 283 | 2 | C2930927 | |
| Disease | long QT syndrome (is_implicated_in) | 1.86e-03 | 7 | 283 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | Seizure, Febrile, Complex | 1.86e-03 | 7 | 283 | 2 | C0751057 | |
| Disease | complement component C9 measurement | 1.86e-03 | 7 | 283 | 2 | EFO_0020282 | |
| Disease | Seizure, Febrile, Simple | 1.86e-03 | 7 | 283 | 2 | C0149886 | |
| Disease | neuropilin-1 measurement | 1.86e-03 | 7 | 283 | 2 | EFO_0020603 | |
| Disease | endoplasmic reticulum aminopeptidase 1 measurement | 1.86e-03 | 7 | 283 | 2 | EFO_0008119 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.89e-03 | 181 | 283 | 7 | DOID:684 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 2.05e-03 | 93 | 283 | 5 | C1535926 | |
| Disease | serum metabolite measurement | TRIO CYP3A5 UGT3A1 CKAP5 NCAPH2 HMGCS2 PGK2 F13A1 PHKB HSPA12A ERAP2 FER KIF26B SYT6 ECHS1 MAP4K5 AKR1C3 ZFHX3 ARMH4 | 2.08e-03 | 945 | 283 | 19 | EFO_0005653 |
| Disease | Glycogen Storage Disease | 2.15e-03 | 27 | 283 | 3 | C0017919 | |
| Disease | Neoplastic Cell Transformation | 2.29e-03 | 139 | 283 | 6 | C0007621 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.29e-03 | 139 | 283 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | Schizophrenia | MYT1L CHL1 EPHX2 CYP2D6 CYP3A5 ABCA13 PTGS1 HSPA12A NRXN1 FGFR1 TBX1 SDHA NPAS2 IPO5 CLOCK SLC12A2 TLR4 ARHGAP18 | 2.34e-03 | 883 | 283 | 18 | C0036341 |
| Disease | HMG CoA reductase inhibitor use measurement | 2.41e-03 | 189 | 283 | 7 | EFO_0009932 | |
| Disease | glutamine measurement | 2.46e-03 | 97 | 283 | 5 | EFO_0009768 | |
| Disease | severe pre-eclampsia (is_marker_for) | 2.47e-03 | 8 | 283 | 2 | DOID:13129 (is_marker_for) | |
| Disease | Unilateral agenesis of kidney | 2.47e-03 | 8 | 283 | 2 | C0266294 | |
| Disease | Chromosomal Instability | 2.47e-03 | 8 | 283 | 2 | C1257806 | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 2.47e-03 | 8 | 283 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | Thrombophilia due to thrombin defect | 2.47e-03 | 8 | 283 | 2 | cv:C3160733 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 2.69e-03 | 99 | 283 | 5 | DOID:11446 (biomarker_via_orthology) | |
| Disease | cathepsin F measurement | 3.16e-03 | 9 | 283 | 2 | EFO_0022038 | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 3.16e-03 | 9 | 283 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | Encephalopathy, Subacute Necrotizing, Infantile | 3.16e-03 | 9 | 283 | 2 | C0751267 | |
| Disease | Encephalopathy, Subacute Necrotizing, Juvenile | 3.16e-03 | 9 | 283 | 2 | C0751268 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QEGDKLMVNVSDISL | 221 | O95150 | |
| FQLTSEDMKVLDGLN | 286 | P17516 | |
| LSENISKFMGLTQVE | 111 | Q99814 | |
| DEADKLLSQDFVQIM | 246 | P26196 | |
| NEEKAMFLISASLQG | 746 | Q6ZSZ5 | |
| QLNFSAMASELEEVK | 371 | Q6ZU80 | |
| KDFIDGNVESLMTEL | 1391 | Q7Z7A1 | |
| MIEDGEIFASINQKD | 341 | Q9UNS2 | |
| LISSNDMKTADELFI | 56 | Q13939 | |
| KAEFQDALEKLNMGI | 316 | P0C0L5 | |
| FGETKSIVELMAIQE | 251 | Q6ZN30 | |
| FQLTAEDMKAIDGLD | 286 | P42330 | |
| VGFMKSAISLAEDEE | 111 | P20815 | |
| LFDLSDNTGKMEVLG | 281 | O14862 | |
| KLNLMSEEVTGQFSV | 126 | P31997 | |
| EADQLLGNTMKDIIT | 446 | Q86TY3 | |
| VESTMEQNFLLDKEG | 366 | Q96QA5 | |
| LNEVFMKLEGQSTIE | 781 | Q8N139 | |
| TDVSLEGKFQMEDLV | 411 | A8K2U0 | |
| EFVSDGLIVMINESK | 891 | Q8WXG9 | |
| EEMKNGTFNTAEVLI | 5231 | Q8WXG9 | |
| DFQEVELILMKNGSS | 76 | Q53H64 | |
| VNLLVGLMEKFADSS | 1706 | Q86UQ4 | |
| DGSISKNDFVMVLEE | 351 | Q9NU02 | |
| GLNDTFKELEFLSMA | 36 | Q9BTT0 | |
| DFLQKGLMISLSTDD | 636 | P23109 | |
| QSVGLLTNELAMEKE | 671 | Q8N283 | |
| DIDGETNLKFRQALM | 271 | O60423 | |
| GSQSEFQKMLIDERL | 26 | Q9Y592 | |
| LQELLDSTMFSKGEV | 216 | Q8IYM0 | |
| RIEDGFSLKEQLQDM | 356 | P01008 | |
| FSLKEQLQDMGLVDL | 361 | P01008 | |
| KAIEKMDIDNFVGST | 476 | Q9NVE4 | |
| KVLETQDLNGDGLMT | 121 | Q99674 | |
| EEQALSMDFKTLTEG | 231 | P49447 | |
| DAFKTQMELLQAGLS | 2476 | Q9P2D1 | |
| KTELQMVQDEAGSLL | 306 | Q8NB25 | |
| TQFEELVGMAEALLK | 106 | Q5SZJ8 | |
| NTFEKNLRAEGLMLE | 181 | Q9BYT9 | |
| KVLNNMEIGASLFDE | 246 | P07205 | |
| NSNAVLMDLDSGDVK | 861 | Q9HBD1 | |
| TAMDTEDQGVKVFLI | 476 | Q9H6Z4 | |
| LGEALVKFKSEEQAM | 441 | Q8IXT5 | |
| EGFNMAKVLASLSDD | 346 | P46060 | |
| FGKIDNIVLMKDSDT | 286 | Q86U06 | |
| FIDDGSNATDLLRKM | 321 | Q8IUH3 | |
| MVKAGNETQISEFLL | 1 | Q8NGA2 | |
| TGMNVELAFLAIAKE | 176 | Q96AX2 | |
| QENELMFLETSALTG | 146 | P20338 | |
| QENELMFLETSALTG | 141 | P61018 | |
| NSELEEKMEKVFQGT | 286 | Q92878 | |
| LSFLGFSDEEKTNME | 276 | Q9H8V3 | |
| QDLKETFIDSGVMSA | 601 | Q96ST2 | |
| MDTNNDGKLSLEEFI | 156 | P84074 | |
| SILQQAGVEMKSEFL | 351 | Q8IXQ6 | |
| LQTTSDGVMLDKDLF | 186 | O94925 | |
| MLEKKDSFVEEGNTL | 1681 | Q14571 | |
| MLASAVEKLNEGFIS | 451 | Q14573 | |
| KDEQIDGEAFLLMTQ | 731 | Q96JM7 | |
| DGEAFLLMTQTDIVK | 736 | Q96JM7 | |
| QSDFGKVTMQFELEV | 601 | Q14680 | |
| SNEEFTQLMLEALDG | 81 | Q99743 | |
| MEEQLDITGSKESLF | 531 | Q96JH8 | |
| VLSKESNFEGQDIKM | 2981 | Q01484 | |
| SKAVENGSEALMILD | 186 | P98082 | |
| VKASVDMFDQLLQAG | 166 | Q96EY7 | |
| MVGVVSDDQDFLDSK | 1 | Q6ZST4 | |
| DNGKTMLNDLLRFDV | 86 | Q8N653 | |
| FMTIEKSTALQEGDV | 1101 | Q8IV33 | |
| AKEVQLFMTDNGLRD | 81 | O15554 | |
| MQENLRFASSGDDIK | 1 | Q8NHV4 | |
| GFDVFNALDLMENKT | 446 | P30419 | |
| EDSGIFTIKNMINTE | 741 | Q16706 | |
| ASNKLGIAMSEEIEF | 111 | O00533 | |
| DKLQISEDVAGATFM | 486 | O60721 | |
| AEKILSMNESGELQD | 211 | A8MXD5 | |
| LNIKRDFLGFMDTDS | 326 | Q8IWI9 | |
| NMELREKFILADGAS | 7381 | Q03001 | |
| FQSLFSLLEELKEGM | 51 | Q9BTV5 | |
| LFNNMEELIKDGSSK | 541 | P52732 | |
| LFLQEQKTLGADDTM | 1161 | P46020 | |
| EKFLMSEDNIDLSGL | 611 | A6NM62 | |
| GLNNMEELVSIDKFA | 291 | O75325 | |
| LILSEMGDDSFNKAA | 1341 | Q2KJY2 | |
| FKMGSENLNEQLEEF | 211 | Q9UKG1 | |
| GTNEETDDLMLTFLL | 971 | Q5SZK8 | |
| MSATFNEDVQALKEL | 196 | Q9NY93 | |
| VASDILNMVFAKLEG | 1581 | Q5CZC0 | |
| TEAALKQVLSFIEMG | 3281 | Q5CZC0 | |
| DKMNSLGVLFLDENR | 446 | P55107 | |
| MEEIFGSLNSLKQDI | 1576 | P12107 | |
| KESVNAAFEMTLTEG | 241 | P30084 | |
| MEIDGFQQLDLEKSV | 1 | A6PVY3 | |
| VKTVLMELFQDSGNT | 141 | P54868 | |
| AVLVDFGLSVQMTED | 266 | P41279 | |
| IDINMSGFNETDDLK | 321 | P13797 | |
| VDSRIEMDSNKGLFI | 186 | Q1X8D7 | |
| MVTEFIFLGLSDSQE | 1 | Q8NH21 | |
| QLEEKDMDIAGFTQK | 1501 | Q92614 | |
| DMDIAGFTQKVVSLE | 1506 | Q92614 | |
| EMNTDTFLEEINKVG | 191 | Q8NDH3 | |
| ESGATKVEDMLTLNE | 736 | Q96JB1 | |
| ATDVDSDNLKLMFVI | 916 | Q5H8C1 | |
| LLAIMNKVSESNGEF | 146 | Q9H0H0 | |
| TLEEFINGMAKDQDL | 151 | O95843 | |
| MDTNNDGKLSLEEFI | 156 | P37235 | |
| FKKGDILQIMSQDDA | 256 | Q5T2T1 | |
| SQQMDDLFDILIKSG | 896 | Q9ULH7 | |
| IDSEKDSLNIVMDQG | 371 | O94830 | |
| DLIQESMAKGDFDNL | 206 | Q9NX36 | |
| GNGETLENFLMVDKD | 521 | Q96LU7 | |
| AELGFKEETLMSQLA | 1306 | Q5T7B8 | |
| EGIISSSKDQDMDIA | 436 | Q9Y2L9 | |
| MDIFLEEDGNVNSKL | 351 | P00488 | |
| DGLVQDEFSESVKMS | 341 | Q9UIQ6 | |
| IFDLMELNGVQADFK | 651 | Q8IWU2 | |
| QTELKNAGFTEAMLE | 746 | Q8IWU2 | |
| EVSEFALDGLKQVMA | 2056 | Q92616 | |
| TAFLMKADLETNAEA | 231 | Q9NSB4 | |
| LKEFIDQMLAEGASL | 131 | Q8WWY8 | |
| GDLKLAQESTMDIEN | 1061 | P12882 | |
| MSGLQSKIEDEQALG | 1091 | P12882 | |
| KENLATLFGDMEDLT | 71 | Q7L590 | |
| EIQTLMQFGDTEIKA | 641 | O43301 | |
| MQFGDTEIKATAIDI | 646 | O43301 | |
| ISNQKMDFKEDLSGI | 741 | P46013 | |
| EEVQLADTMFGLTKV | 171 | Q96RR1 | |
| KVLNNMEIGTSLFDE | 246 | P00558 | |
| DLFIDGQSKDIRQMA | 646 | Q9ULB1 | |
| SFQELVGEKEMAAEL | 476 | P23219 | |
| LAVGKEKFMQDASDV | 566 | O00410 | |
| ELTFDQEFMADLIKQ | 151 | O15442 | |
| QLMTKGESEALSQIF | 246 | Q96KD3 | |
| SDFLSLVQGIMDLQE | 231 | Q92832 | |
| DNDTFENMGASLKIL | 316 | Q7Z2Q7 | |
| DTDNTEMLIFIIAGS | 191 | Q8N146 | |
| EFEGKLLAQVSMAEF | 191 | Q9NYR8 | |
| FSNSENLEKLEKLGM | 201 | Q9H0J9 | |
| LSSLDLIKMDEGVNF | 761 | A2PYH4 | |
| MKLSSIDLNDQVEGD | 5951 | Q5VST9 | |
| MDISEGNKTLVTEFV | 1 | Q9NZP5 | |
| SELENLVLKDMSDGF | 96 | P13674 | |
| LDELMASLSDFKIQG | 266 | P49023 | |
| LKEMDNAGQLVFLAT | 271 | P50897 | |
| NEERLFGSQEIMTEK | 466 | Q92794 | |
| NMEKDNGLDVFKLSD | 3246 | Q9P2D7 | |
| LLSQIDAEFEKMQGQ | 801 | Q14008 | |
| EMVTFLDKLGLSQAV | 316 | P34913 | |
| VTMELITDNKDFTGI | 696 | Q4AC94 | |
| EATKAVTQLELFGDM | 271 | O75553 | |
| IAKLEFTDNLEIVGM | 1206 | Q8TD57 | |
| FTDNLEIVGMISSEK | 1211 | Q8TD57 | |
| IKGQVLMSSELEEVF | 3901 | Q8TD57 | |
| SAEMIDFQKSQGDIL | 436 | P16383 | |
| VTEDNVMKIADFGLA | 631 | P11362 | |
| NVLKISDFGMSRQED | 696 | P16591 | |
| LDAMDIKGQESSSDQ | 641 | Q96JM3 | |
| LTEAFLAEMEKAKGN | 271 | P10635 | |
| MEIKGNLFSNKDLEE | 821 | Q8TF46 | |
| MADSVKTFLQDLARG | 1 | O14681 | |
| DEFMKLLGISSDVIE | 16 | P51161 | |
| KDFSELRSAGVEQLM | 236 | Q14320 | |
| MDDSETGFNLKVVLV | 1 | Q5TA50 | |
| EMQGVFLFTDTQIKE | 2391 | Q8WXX0 | |
| KVAVLLMDTQGAFDS | 166 | Q8NHH9 | |
| DMLGSLRDSALFVKN | 101 | Q9H3Q1 | |
| GFVTMTLESLEEIQD | 586 | Q9BQ39 | |
| MQLADGIFETLIKDT | 3086 | Q5VT06 | |
| DGMEEIFGSLNSLKL | 1606 | P20908 | |
| LGDSKMSFEDIKANV | 306 | P05108 | |
| ETITEEELVGLMNKF | 161 | P16152 | |
| MGELTSKEFEAILNR | 706 | Q0VDD8 | |
| EGKATDEDMQSLASL | 161 | Q8NDI1 | |
| GQIELELATAKSDMN | 436 | Q5TF58 | |
| QMLQSFGTELAETEL | 246 | O15068 | |
| RGILKSIASADMDFN | 56 | Q8N668 | |
| TSNMLAFLGENAEVK | 521 | Q6P179 | |
| GDMNADQLASKLEET | 211 | O43681 | |
| GDSFRMKLNTQEIFD | 686 | Q14204 | |
| KMFAGVSSIILNEDN | 1656 | Q14204 | |
| NESIVVDMKSGFNLE | 416 | Q9BVP2 | |
| VDMKSGFNLEELEKN | 421 | Q9BVP2 | |
| LNGLMKDLSEFSVIV | 551 | Q12840 | |
| QSVKTEAEELFGETM | 1106 | Q13751 | |
| TFLNGLTVADMEDLL | 331 | Q8WUQ7 | |
| MQENFDIEVSKSIDG | 321 | Q8NEL9 | |
| GQNDLEKMTSILEAV | 106 | P36959 | |
| VDMSGLQAKNEILSE | 956 | A2RUR9 | |
| DKVGTDMLEEQITAF | 196 | P24534 | |
| SLMDTSGNGKLEFDE | 571 | O14815 | |
| QLESRKESMGFEELS | 2271 | Q9C0D2 | |
| IAEMDFANLTLEEKS | 2411 | Q9C0D2 | |
| AEEGFLELINNMLTS | 2866 | Q8IVF4 | |
| SESFTLEQIVELGMD | 1331 | Q9P225 | |
| KELAGMFLSEDENFL | 81 | O76038 | |
| MTDKLAFDVGLQEDA | 126 | P21817 | |
| INMLLQFKDGTDEED | 2006 | P21817 | |
| ISELLGMDKAALDFS | 4666 | Q92736 | |
| DSLEMNAKGVILNAF | 81 | Q16820 | |
| MDTNRDGKLSLEEFI | 156 | P61601 | |
| DNFVDKLKSEGETIM | 236 | P48444 | |
| TINNMAGLEVTVDFK | 856 | Q8NG08 | |
| IETGDSKMNLNDFIS | 166 | Q96HA8 | |
| KAEFQDALEKLNMGI | 316 | P0C0L4 | |
| KDGQLTDDEMFSNEI | 211 | Q5VVW2 | |
| LQDSTIEGLEDMATK | 496 | Q8TE73 | |
| EMNFSLLVEDTLGNI | 976 | Q93100 | |
| LQDQVSIGAMDTLEK | 1176 | P46019 | |
| GSEKETMQFLNDRLA | 91 | O76013 | |
| GDDFSLIQQEIFMVK | 56 | Q9Y4K4 | |
| LKADDMGEINQTLVS | 26 | Q8NGS6 | |
| MENNTEVSEFILLGL | 1 | Q8NGF7 | |
| FAIDQETGNITLMEK | 756 | Q9BZA8 | |
| EQSADMATALLAGEK | 6 | Q96RD6 | |
| DFILTGLSDSEEVQM | 11 | Q8NGG4 | |
| ILLDDNMNIKLTDFG | 156 | Q16816 | |
| QSEEDLAALFEASMK | 451 | Q8IWW8 | |
| MEETNNSSEKGFLLL | 1 | Q5TZ20 | |
| MVTEFIFLGLSDSQE | 1 | Q96R69 | |
| NLMDGELGEIKNITT | 1131 | O60469 | |
| EITAETFMEKLDNGA | 51 | O43903 | |
| DMIGEVILDNLFEAS | 326 | Q5T7P8 | |
| VTNDNVDLGELMFSL | 346 | Q86SS6 | |
| MESFVKSLDGDVQEL | 161 | O75031 | |
| VANTMEDFQKILDSG | 1426 | P07814 | |
| FDMKDLNASVVNIDT | 1016 | Q6YHU6 | |
| VTKNDVMNLLESAGF | 116 | Q9UQE7 | |
| DTVGFLLDLNEKQMI | 426 | Q96DX4 | |
| EKLQMSSDDGASLLF | 451 | Q13424 | |
| VKSAIDLEEMASGLN | 56 | P61011 | |
| MQTRILKQDLTGDFE | 386 | Q96DN5 | |
| ILEMTNIDGKSQFVS | 216 | Q9BXR5 | |
| SAVLLEGMNKETFNL | 371 | Q8N4U5 | |
| KLLFNEEAMGKVDAS | 501 | Q8N4U5 | |
| ESVMNLDKLRFADGS | 491 | P31040 | |
| GSEKETMQFLNDRLA | 96 | O76011 | |
| TMTKALQNVLDLDGD | 481 | Q17RQ9 | |
| MSDNELEGRLVTKFS | 246 | Q5SWL7 | |
| KEFGSMVLELNASDD | 81 | P40937 | |
| NGTDLLADENFLMVT | 411 | Q8IZX4 | |
| ATTDNGIQMKIAEFL | 556 | Q8NE18 | |
| KLLQFQDLTGIESMD | 16 | Q96CS3 | |
| DGDNTSMFAKILDAI | 306 | Q9NXP7 | |
| EMLLNEKGEFTIETE | 531 | P41250 | |
| TEIQEMEFLQFSKGL | 261 | Q8IYU8 | |
| QTEEAKAEALVLMGT | 511 | O14802 | |
| SVDDVVVLGMNLSKF | 61 | Q9H1N7 | |
| ADQAFLVLMETIEGA | 96 | Q9Y4R8 | |
| MANSLLEGVFAEVKE | 1 | Q5VXD3 | |
| AFQEQEIDGKSLLLM | 71 | Q5VXD3 | |
| GDLKLAQESTMDTEN | 1061 | Q9Y623 | |
| SKIFEDQAADQTGML | 101 | Q9NY99 | |
| VIKTDMFQTVDLFEG | 106 | Q01995 | |
| VTDLFNQVKADLSGM | 306 | Q96P15 | |
| KGLTDEEIDMAFQQS | 56 | O75381 | |
| KLSMELEGNDGLSFI | 1011 | Q9NRY4 | |
| NSILQDMGITDIFDE | 311 | Q96P63 | |
| EKQGLEAMEEILTSS | 376 | Q12765 | |
| QGDMEKSLQFELIAA | 196 | Q9Y5Q9 | |
| FQLTSEEMKAIDGLN | 286 | Q04828 | |
| FQLTSEEMKAIDGLN | 286 | P52895 | |
| AGKDLQDNFLTALAM | 86 | Q6V702 | |
| SNEEFTQLMLEALDG | 106 | O15516 | |
| LRKMGSNLTASEEEF | 26 | Q9NSA3 | |
| EMELLDGKQTLAAFV | 1001 | Q15021 | |
| EGKTTMNFIEAALLI | 46 | Q6IBW4 | |
| MGFSEEEQLSILKVV | 336 | P35749 | |
| LQGSKQEMTDLFEIL | 1431 | Q96JI7 | |
| NGVDLSMEANAIALK | 1056 | Q15468 | |
| ESEALVKLMEIFGTQ | 106 | Q6NUS8 | |
| ENVSKLVESGIQFMD | 256 | Q9BYV6 | |
| DVMQETFKNLASIGE | 31 | Q3KP31 | |
| LNSIDQTGELLAMFE | 141 | O75486 | |
| EMESGASAKALNEAL | 861 | P49588 | |
| VIGALESAFKEMDLQ | 241 | Q9ULR3 | |
| EINKNVMSAFGLTDD | 176 | Q92734 | |
| DESKEIAESSMFNLL | 191 | Q99962 | |
| GNSSESLEEKDIQME | 81 | Q9Y458 | |
| FLQVEQKMAGVTLES | 266 | O75038 | |
| RKMTEFGNLALIDQD | 661 | Q15269 | |
| DMLESGKLAIFTDDI | 166 | P61266 | |
| GKLAIFTDDIKMDSQ | 171 | P61266 | |
| IDFSDIMVLGDINTK | 1081 | P55011 | |
| GTNDFREFVLEMQKT | 1381 | Q92626 | |
| DAIEFAQLMVKAASA | 121 | Q6ICG8 | |
| GIELLQMVLNFDTKD | 531 | Q9HAV4 | |
| AILTLKESFEGQMTE | 191 | P25787 | |
| GKLEQSLRLMEEASF | 251 | Q13077 | |
| KLFMEQEDVGLGELS | 191 | Q9Y4E1 | |
| EEEGVKMSAKILNFS | 106 | Q6AHZ1 | |
| AKLLEEMDQEFGVST | 221 | O43290 | |
| LKGKSQAFLEMASEE | 91 | O95758 | |
| ALGLKSSEQREFVMA | 491 | Q8N392 | |
| KEVMLENFSNLVSVG | 61 | Q3KNS6 | |
| KLFMEQEDVGLGELS | 191 | Q641Q2 | |
| AGNEKLELAMLSFFE | 541 | Q9UIA9 | |
| VDAENMLEALKNSSG | 131 | O43149 | |
| VELDSQLLGKMAFEE | 391 | O75541 | |
| DEFNQLGTEMIVTKA | 121 | O43435 | |
| KMGEEESQFLLSLQA | 2451 | Q70CQ2 | |
| FNSAIVMQESGEVKL | 636 | Q6ZXV5 | |
| FMKASVDVADLIGLN | 71 | Q9BVK8 | |
| TAEELMNFSKGEENL | 261 | P50990 | |
| SSLEVLKMAGNSFQE | 471 | O00206 | |
| EADGNKTMIELSDNE | 641 | Q93009 | |
| KFEFETNMVSLEGLT | 176 | O75962 | |
| LSELTDQMTFGERIK | 206 | P0DTE5 | |
| LLTAGFQTLEKIEDM | 211 | Q15776 | |
| TKMFEGEALLSQDAE | 36 | Q49AA0 | |
| QLVSEELMNLGESFI | 921 | Q15911 | |
| SNILKMAEDEAETIG | 436 | O00629 | |
| VTDEMFLEALNSKLG | 466 | O94832 | |
| EEVFDMTKGNLTLLE | 421 | Q9UL68 | |
| EFTSDDLLAQGDMKQ | 796 | P19838 |